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Fructose-1,6-bisphosphate (FBP) aldolase (E.C. 4.1.2.13) catalyzes the reversible aldol 
condensation of dihydroxyacetonephosphate (DHAP) and glyceraldehyde-3-phosphate (G3P) in 
glycolysis, gluconeogenesis and the Calvin cycle. FBP aldolases are categorized into two groups 
based on different catalytic mechanisms: Class I aldolases form a Schiff-base intermediate with 
the substrate through an active site lysine residue, whereas Class II aldolases contain a divalent 
metal which coordinates and stabilizes the carbanion intermediate. Notably, Class II aldolase 
does not exist in animals or plants, making this enzyme a potential drug target for pathogenic 
microbial organisms such as Mycobacterium tuberculosis, Pseudomonas aeruginosa, 
Magnaporthe grisea. A chromogenic substrate was synthesized as a FBP mimic from DHAP and 
4-nitrobenzaldehyde catalyzed by a chiral primary-tertiary diamine-Brønsted acid catalyst that 
was synthesized in the optically active form. The chromogenic substrate can be applied to a 
direct chromogenic assay for monitoring the activity of Class II FBP aldolases and also to 
evaluate any good inhibitor. The catalyst was also synthesized in the racemic form that is ready 
for future asymmetric aldol reaction studies. In addition, our research group has found that a 
commercially available antidote for heavy metal poisoning, 2,3-dimercapto-1-propanesulfonic 
acid (DMPS) is a good competitive inhibitor of Class II FBP aldolase. In order to improve the 
binding affinity of this inhibitor in the enzyme active site, new molecules based on this 
compound, 1,1-difluoro-3,4-dimercaptobutylphosphonic acid, was rationally designed using 
molecular modeling. Attempts to synthesize this compound using our original synthetic plan 
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1.1 Overview of aldolases 
Historically, aldolases were first recognized near the beginning of the last century as a class of 
enzymes which are present in all organisms that are able to catalyze the interconversion of 
hexoses and their three-carbon components. Meyerhof and coworkers first described the activity 
of aldolases and originally named them zymohexases (1). Later on aldolases were found to 
accept a much wider range of substrates than hexoses, and were found to be capable of adding a 
one-, two- or three-carbon fragment stereospecifically to an aldehyde via the aldol condensation 
reaction. To date, aldolases have been one of the most useful classes of enzymes in the formation 
of monosaccharides, although only a few of them have been exploited synthetically (2).  
 
1.2 Catalytic roles and synthetic application of fructose-1,6-bisphosphate aldolase 
Fructose-1,6-bisphosphate (FBP) aldolases (E.C. 4.1.2.13) play important catalytic roles in 
metabolic pathways such as glycolysis, gluconeogenesis and the Calvin cycle in different 
organisms by catalyzing the reversible aldol condensation reaction of 
dihydroxyacetonephosphate (DHAP) and glyceraldehyde-3-phosphate (G3P) (Scheme 1-1) (3). 
In each of the pathways, the enzyme-catalyzed reaction involves deprotonation and protonation, 
formation of an enzyme-DHAP intermediate and eventually the release of G3P and DHAP 
molecules from the enzyme active site (4). The exquisite control of stereochemistry of aldol 



































Scheme 1-1. The general reaction scheme of the reversible aldol condensation reaction catalyzed 
by FBP aldolase. DHAP and G3P combine to form into FBP in the direction of aldol 
condensation; conversely, FBP can be cleaved into DHAP and G3P in the reverse direction. 
 
 
to the conventional chemical methods in the field of synthetic chemistry. It has already been 
shown to be excellent for the synthesis of compounds in the pharmaceutical industry, such as 
13C-labelled, nitrogen or fluorine containing sugars, and novel high carbon sugars (5), as well as 
glycosidase inhibitors such as deoxynojirmycin and deoxymannojirmycin (6). FBP aldolases are 
highly specific for DHAP, whereas they accept a large variety of acceptor aldehydes, such as 
unhindered aliphatic aldehydes and α-heteroatom-substituted aldehydes (7). Generally, 
phosphorylated substrates are preferred over non-phosphorylated ones (7, 8).  Furthermore, 
DHAP-dependent aldolases can create two new stereogenic centers with excellent 
enantioselectivity and diastereoselectivity. Principally, there are four possible 
stereoconfigurations at C3 and C4 of the products, while FBP aldolases are strictly specific for 
the 3S, 4R stereoconfiguration (9). 
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1.3 Two mechanistic classes of FBP aldolases  
        The retro-aldol cleavage by FBP aldolase is catalyzed by stabilizing the enolate 
intermediate through increased electron delocalization, which is contributed by the active site of 
the enzyme. Although all FBP aldolases adopt the (α/β)8 barrel fold structure, they are 
categorized into two different classes according to the reaction mechanism which they employ to 
stabilize the enolate intermediate in the enzyme active site, namely Class I and Class II aldolases 
(3, 10). Class I FBP aldolases use one ε-amino group of a lysine to prompt the formation of a 
Schiff-base intermediate, whereas Class II FBP aldolases use a Zn2+ cation to stabilize the 
enolate intermediate. Class II FBP aldolases can also be activated by monovalent cations such as 
Na+ (3). 
 
1.4 Class I FBP aldolases  
 
1.4.1 Characteristics of Class I FBP aldolases 
Class I aldolases are present predominantly in higher organisms such as animals, plants, green 
algae, certain prokaryotes and archaebacteria (10-12). Generally, Class I aldolases are found to 
be tetramers in eukaryotes, with an approximate molecular weight of 160,000 kDa; however, it 
has also been reported that they can exist as monomers to decamers in prokaryotes (11, 13, 14). 
The Class I enzymes have been studied extensively and a number of their three-dimensional 
structures have been determined by X-ray crystallography, including the FBP aldolases from 
rabbit muscle (15), Drosophila melanogaster (16), human muscle (17) and the dimeric 
Escherichia coli transaldolase B (18). Interestingly, Class I aldolases such as rabbit muscle 
aldolase (RAMA), possesses a broader functional pH range (pH 7-9) than Class II aldolases, 
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which exhibit a very sharp pH optimum. Furthermore, all the Class I FBP aldolases lose activity 
upon the addition of NaBH4 in the presence of the substrate, whereas they are insensitive to 
EDTA. It has also been reported that Class I aldolases can be subdivided into 3 different organ 
specific isozymes in animals: isozyme A, the major form in muscles; isozyme B, found in liver 
and kidney, while not detected in other organs; isozyme C is present in brain tissue together with 
isozyme A (10). 
 
1.4.2 Catalytic mechanism of Class I FBP aldolases 
    A general catalytic mechanism of a Class I FBP aldolase was proposed by Gefflaut et al. (19) 
based on results from crystallographic data, kinetic studies and site directed mutagenesis using 
RAMA (Scheme 1-2). Initially, DHAP enters the active site and binds to Arg-148 through the 
coordination of its phosphate group. Then Lys-146 and Glu-187 participate by aiding in the 
polarization of the carbonyl group of DHAP and induce the formation of the Schiff-base 
intermediate between the carbonyl and the ε-NH2 group of Lys-229. Subsequently, a C3 proton 
abstraction by Tyr-363 from the imminium leads to the formation of an enamine. Hereafter, G3P 
binds to the active site with its phosphate group oriented by Lys-41, Arg-42 and Lys-107. The 
activated double bond of the enzyme-DHAP adduct attacks the electrophilic carbon of the G3P 
carbonyl group and a new C-C bond is formed through condensation yielding FBP.  
 
Notably, Class I aldolases in animals share a sequence homology of amino acid residues in the 
enzyme active site, particularly in the region adjacent to the lysine residue (Lys-229) which 









































Scheme 1-2. Generalized catalytic mechanism of Class I FBP aldolase. The enzyme catalyzes 
the reaction by forming a Schiff-base intermediate with the carbonyl group of the substrate 
DHAP which is then ionized into an enamine. The double bond of the enamine attacks the 



















1.5 Class II FBP aldolases 
 
1.5.1 Characteristics of Class II FBP aldolase 
Unlike Class I FBP aldolases, which are found mainly in animals and higher plants, Class II 
FBP aldolases are present in lower organisms such as bacteria, fungi, algae and protozoa, with 
the co-existence of both classes in some organisms (21, 22). The Class II FBP aldolases are 
further divided into two groups according to their primary sequences: the Class IIa enzymes, 
which comprise the FBP aldolases and are generally characterized to be dimeric with an average 
molecular weight of 70,000 kDa; and the Class IIb enzymes, which consist of tagatose-1,6-
bisphosphate aldolases as well as other FBP aldolases, and can be found as dimeric, tetrameric or 
octameric forms (10, 23). Members of each subclass exhibit 40% sequence similarity, with 25-
30% sequence similarity among all Class II FBP aldolases (13).  
 
Compared to Class I FBP aldolases, which have been extensively studied, less is known about 
Class II FBP aldolases. The first Class II aldolase structure obtained was fuculose-1-phosphate 
aldolase, and its catalytic mechanism was derived from structure-directed mutagenesis studies of 
the enzyme active site (24, 25). In addition, only a few crystal structures of Class II FBP 
aldolases are available, such as the dimeric Escherichia coli (26) and Giardia lamblia aldolases 
(27), as well as the tetrameric Thermus aquaticus (28) and Thermus caldophilus (29) aldolases. 
Moreover, the crystal structure of Class II FBP aldolase from Mycobacterium tuberculosis has 
just recently been reported (30). Although Class I and Class II FBP aldolases possess the same 
(α/β)8 barrel fold structure and catalyze the same overall reaction, they share only 15% sequence 
homology (31) and the locations of their active sites are different, suggesting an independent 
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evolutionary pattern (32). Recent studies based on primary structure alignments have led to the 
suggestion that these enzymes may have evolved independently from a common (α/β)8 barrel 
ancestor as is the case for other families of (α/β)8 barrel fold enzymes (33, 34).  
 
1.5.2 Enzyme active site in the Class II FBP aldolase of Escherichia coli 
Little was known about the Class II FBP aldolases and the details of their enzyme active sites 
before the structure of the dimeric Class II FBP aldolase from E. coli was determined using data 
to 2.5 Å resolution by Cooper et al. (26). The enzyme was shown to be a homodimer (Figure 1-
1), and each dimer is approximately 100 Å in length with the β-barrels positioned nearly at right  
 
Figure 1-1. Schematic representation of the structure of the dimeric E. coli FBP aldolase. The 
chain A is colored in red and the chain B is colored in blue. Furthermore, the α10 and α11 
helices of monomer A are colored in pink and purple, respectively. The important amino acid 
residue Arg-331 which is responsible for substrate recognition and binding is highlighted in 
yellow in a ball-and-stick fashion. M1 and M2 are displayed in CPK style and colored in grey 
and green, respectively. The model was derived from PDB 1B57 using Viewerlite (Acceryls) 
(35).  
 7
angles to each other. Two α-helices (α10 and α11, Figure 1-1) are antiparallel to each other, and 
create an association via van der Waals interactions, hydrogen bonds plus a salt bridge formed 
between Arg-344 and Asp-290, which are important for the dimerization. These two helices then 
associate with the identical structure on the other subunit through the C- and N-terminal regions, 
and these interactions produce a substantial hydrophobic core at the dimer interface (26). 
Furthermore, the use of site-directed mutagenesis in combination with the arginine specific 
reagents butanedione or phenylglyoxal by Qamar et al. identified Arg-331 of the helix α11 to be 
an important residue in terms of substrate recognition and binding (36). The crystal structure 
showed that this residue is located at the N-terminus of helix α11 within the active site and 
approximately 13 Å from the catalytic site of the other subunit.  Subsequent sequence alignment 
of the eight known Class II FBP aldolases showed that Arg-331 is the only arginine residue 
conserved among all the known sequences (Figure 1-2), which has confirmed the critical role of 





Figure 1-2. Sequence alignment of the active site region of Class II FBP aldolases. The sequence 
alignment of the active site region from eight different microorganisms T. aquaticus, T. 
caldophilus, P. aeruginosa, G. lamblia, B. cereus, E. coli, M. grisea and M. tuberculosis. Arg-
331 of E. coli is shown to be the only conserved arginine residue in the eight microorganisms. 
The alignment was done by using the ClustalW program and the graphic representation was done 
by GeneDoc program. The GenBank accession numbers are AY945938, CAF32659, AAG03944, 
NP_249246, NP_834997, P0AB71, XP_369021 and NP_214877, respectively.   
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Numerous enzymes adopt the (α/β)8 barrel structure utilizing either a single or multiple ions 
for catalysis. Despite the similarities with some structural features compared to other 
metalloenzymes, the E. coli Class II FBP aldolase was proposed by Cooper et al. to possess a 
bimetallic-binding active site with two metals 6.2 Å apart. One metal ion termed M1 is buried 
and presumed to be potassium, zinc or some other cations, possibly playing a structural or 
activating role; whereas the other termed M2 (a Zn2+ ion) is positioned on the surface of the 
active site, participating in the catalytic reaction (see Figure 1-1). M2 presents a distorted 
tetrahedral geometry and it is coordinated to three histidine residues (His-110, His-226 and His- 
264) and Glu-174 (26). Further studies by Hall et al. confirmed that the two metals in the crystal 
structure obtained by Cooper et al. to be only one zinc ion in two mutually exclusive sites with 
50% occupancy in each site (35). Furthermore, zinc containing enzymes can be divided into two 
groups based on the number of zinc ions: the mono-zinc system and the co-catalytic, or coactive 
sites. The latter group of enzymes contain two or more zinc atoms, bridged by an acidic residue 
and a water or hydroxide ion (37-39).  
 
1.5.3 The catalytic mechanism of Class II FBP aldolase 
Class II FBP aldolase uses a different catalytic mechanism as compared to Class I FBP 
aldolase. The crystal structure of Class II FBP aldolase of E. coli in complex with a transition 
state enediolate analogue and inhibitor phosphoglycolohydroxamate (PGH) has been determined 
using X-ray diffraction with a resolution of 2.0 Å (35). Based on the structural information and 
in conjunction with the results generated using site-directed mutagenesis, steady- state kinetics 
and Fourier transform infrared spectroscopy, a detailed mechanism involving the catalytic zinc 




















































































































Scheme 1-3. The proposed mechanism of E. coli Class II FBP aldolase. Details of the 
mechanism are discussed in the text (35). 
 
 
In step I and step II, DHAP initially approaches and binds to the active site, which results in an 
active site rearrangement. DHAP then binds with the carbonyl and hydroxyl oxygens to Zn2+ 
which is coordinated by His-226, His-110, and His-264, replacing the two water molecule 
ligands observed in the crystal structure (36). Then the direct coordination of DHAP to the zinc 
assists the precise alignment for catalysis, facilitating zinc to function as a Lewis acid and to 
polarize the carbonyl bond of the substrate, while increasing the acidity of the hydrogen atoms 
on C1. The active site residues restrict the access of the electrophilic G3P to the si-face of DHAP. 
Subsequently, the loop carrying Glu-182 undergoes a conformational change to position the 
residue closer to the catalytic zinc, and Glu-182 acts as a general base to abstract the acidic 
proton, prompting the formation of the enediolate transition intermediate which is stabilized by 
the Asn-286 positioned just below it (not shown in Scheme 1-3). In step III and IV, G3P binds to 
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Arg-331 and is brought into the position to interact with the enediolate intermediate. Asp-109 
then polarizes the C1 carbonyl group of G3P and facilitates the nucleophilic attack of the C1 
carbon of the enediolate to the carbonyl acceptor, hence the formation of the FBP product.  The 
two planes of the enediolate intermediate and the carbonyl group of G3P must be near-parallel in 
the initial alignment ahead of the C-C bond formation. In Step IV, Asp-109 transfers a proton to 
convert the C4 carbonyl group to a hydroxyl group either in concert with or right after the C-C 


















1.6 Class II FBP aldolase as a potential drug target 
        Since Class II FBP aldolase is not present in higher organisms such as animals or plants, it 
has been suggested as a viable drug target (31, 40). In several pathogenic microorganisms, 
especially Mycobacterium tuberculosis and Pseudomonas aeruginosa, the rice blast causative 
agent Magnaporthe grisea, anthrax causative agent Bacillus anthracis, or bacterial meningitis 
causative agent, Streptococcus pneumoniae and Haemophilus influenzae, inhibitors of Class II 
FBP could be used as antifungal or antibacterial agents. 
 
    Tuberculosis (TB), the most common contagious pulmonary disease, is caused by infection 
with the human pathogen Mycobacterium tuberculosis. Statistics from the World Health 
Organization indicate that approximately 9.2 million new cases emerged in 2006, with 1.7 
million M. tuberculosis-related deaths, and this is an increase over the 9.1 million new cases 
reported in 2005 (41). Today, TB is still the leading cause of deaths among young and middle-
aged adults apart from acquired immune deficiency syndrome (AIDS). It was estimated that one-
third of the world’s population is currently infected with TB bacilli; meanwhile, every second 
there is someone in the world being infected (42). It has been approximately 30 years since the 
introduction of a novel drug for TB. Strains which are resistant to a single drug or even a 
particularly dangerous form, multidrug-resistant TB (MDR-TB) bacilli have emerged in the 
latent stage of the infection, due to inconsistent or partial treatment. Patients with MDR-TB must 
be treated with extensive chemotherapy (up to two years treatment), generally a combination of 
second-line anti-TB drugs which are not only more expensive, but also more toxic and less 
effective (42). Therefore, to shorten the duration of the treatment and the frequency of drug 
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administration, and to improve the effective treatment of MDR-TB and latent tuberculosis 
infection, there is a definite need for new drug discovery and development (42).  
 
Interestingly, like E. coli, M. tuberculosis is one of the few organisms which contain both 
Class I and Class II FBP aldolases (43, 44). Generally, if the microorganisms possess both 
classes of enzymes, only one of them is constitutively expressed (45). In the case of E. coli and 
other prokaryotes, the gene which encodes Class II FBP aldolases is essential and constitutively 
expressed; nevertheless, the non-essential Class I FBP aldolase gene is induced by the presence 
of gluconeogenic substrates (43, 46). Noticeably, temperature-sensitive E. coli mutants of Class 
II FBP aldolase were unable to grow on media containing trace amounts of glucose due to the 
denaturation of the enzyme. Ultimately, the accumulation of FBP in the host was shown to 
inhibit stable rRNA synthesis when the experimental condition shifted to non-permissive 
temperatures (47-49). It was confirmed that Class II FBP aldolase is also constitutively expressed 
in M. tuberculosis since the enzyme could be purified at both high and low oxygen tension, 
whereas Class I FBP aldolase could only be obtained at high oxygen tension, which is consistent 
with studies on the E. coli fba gene (43). Further proteomic analysis on M. tuberculosis indicated 
that Class II FBP aldolase (fda, Rv0363c) was one of only seven proteins expressed under 
hypoxic conditions, supporting the idea that low oxygen tension was considered to be 
responsible for the emergence of latent TB (50). Single-gene knockout attempts of the E. coli 
fbaA gene (Class II) have proven to be unsuccessful, while knockout of the fbaB is viable (51, 
52). Attempts to replace the wild-type fba gene (Class II) in M. tuberculosis with a deleted allele 
(Δfba) by a two-step homologous recombination procedure have also proven to be unsuccessful 
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(30). Therefore, Class II FBP aldolase appears to be essential and is a very promising target for 
development of the novel drugs against TB.  
 
    Cystic fibrosis (CF) is a severe chronic respiratory and genetic disease which mainly arises 
from the mutation in the cystic fibrosis transmemberane conductance regulator gene, which 
decreases natural defence against bacterial infection, resulting in the infection of most of the 
patients with the microbial pathogen Pseudomonas aeruginosa in infancy and early childhood. 
Ultimately, around 80 to 95% of the CF patients succumb to the declined pulmonary function 
and respiratory failure due to chronic bacterial infection and concurrent airway inflammation 
(53).  
 
The main aspect of the pathogenesis of chronic lung infection in CF is the capability of P. 
aeruginosa to develop a biofilm in the respiratory pathway, which was reported to be responsible 
for the increased bacterial resistance to phagocytic and antibiotic killing (53). The current 
definition of a bacterial biofilm was given by Costerton et al. (54) as “a structured community of 
bacterial cells enclosed in a self-protected polymeric matrix and adherent to an inert or living 
surface”. Within the biofilms, sessile bacterial cells release antigens which can stimulate the host 
to produce antibodies; however, the antibodies produced are not effective in inhibiting the 
bacterial growth inside the biofilms compared to the susceptible floating bacteria. Gradually, the 
accumulated phagocytic enzymes which are not able to penetrate the biofilms will damage the 
tissues around the biofilm, resulting in further infection by the floating bacteria and 
accompanying symptoms (54). It was reported that in P. aeruginosa FBP aldolase is essential for 
the synthesis of the alginate coat, a polymer of selected acetylated D-mannuronate and L-
 14
guluronate which is believed to be responsible for one of the independent pathways for biofilm 
formation (49, 55). Furthermore, mutants of Class II FBP aldolase in P. aeruginosa were found 
unable to grow on gluconeogenic precursors such as glutamate, succinate or lactate (56). Hence, 
drugs targeting Class II FBP aldolase in P. aeruginosa may be able to interrupt the formation of 
the biofilms and significantly increase the sensitivity of these pathogenic bacteria to antibiotics 
and the immune system.  
 
1.7 Research Objectives 
Overall, this research will focus on the development of novel small molecule compounds 
which will be tested and evaluated against Class II FBP aldolases in pathogenic microorganisms 
M. tuberculosis and P. aeruginosa as inhibitors. In addition, a direct chromogenic assay for 
monitoring Class II FBP aldolase enzyme activities and evaluation of lead Class II FBP aldolase 
inhibitors will be developed, for which chromogenic substrates mimicking FBP will be 
synthesized. Synthetic details of the chromogenic substrates and application of those compounds 
in the direct chromogenic assay are presented in chapter 2. The development and synthesis of 













Development of a direct chromogenic assay for monitoring Class II 
FBP aldolase enzyme activity 
 
2.1 Introduction 
    Previously, our research group had been using a coupled NADH-linked enzymatic assay as 
reported in the literature (1, 2) to examine the activity of purified Class II FBP aldolase enzymes. 
The assay as depicted in Scheme 2-1 is based on the fact that DHAP can be converted to 
glycerol-3-phosphate by α-glycerolphosphate dehydrogenase (GPD) accompanied by the 
simultaneous oxidation of NADH into NAD+, while rabbit muscle triose phosphate isomerase 
(TIM) is able to catalyze the conversion of glyceraldehyde-3-phosphate (G3P) into DHAP. 
NADH absorbs readily at 340 nm and the quantitative reduction of the absorbance can be 
monitored to determine the relative enzyme activity. This assay is simple and convenient to 
evaluate the inhibitory activity of potential candidate compounds towards Class II FBP aldolases. 
However, it is possible that non-specific inhibition by the candidate compounds being examined 
in this coupled assay towards the other coupled enzymes such as TIM or GPD could give false 
results. 
FBP FBP aldolase DHAP
    +
G3P
GPD




Scheme 2-1. Schematic representation of the NADH-linked coupled-enzymatic assay. TIM 
catalyzes the conversion from G3P into DHAP. GPD catalyzes the conversion from DHAP to 
glycerol-3-phosphate, coupled by the oxidation of NADH. NADH absorbs at 340 nm and the 
enzyme activity is monitored by the quantitative reduction of absorbance A340.  
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     Specifically in this coupled NADH-linked enzymatic assay, TIM is responsible for catalyzing 
the stoichiometric conversion from G3P to DHAP. Therefore, non-specific inhibition towards 
TIM by any candidate compound leads to less formation of DHAP, hence less conversion from 
DHAP to glycerol-3-phosphate. Moreover, non-specific inhibition towards GPD will also result 
in less formation of glycerol-3-phosphate. In this case, the assay will exhibit slower rate of 
NADH quantitative reduction, giving the false conclusion that the candidate compound is 
exhibiting specific inhibitory activity towards Class II FBP aldolases. In addition, NADH and the 
coupling enzymes make the assay relatively expensive, especially for practical use in large scale 
screening of potential inhibitors which may need to be done in future, if the rationally designed 
inhibitor proves to be inadequate. To circumvent these problems, a direct assay involving only 
Class II FBP aldolases rather than this multiple coupling enzyme system is the goal of the 













2.2 Design of chromogenic substrates 
    Theoretically, for a direct enzymatic assay, part of the substrate should be a chromophore that 
can be detected spectrophotometrically. The basic strategy is to design and chemically synthesize 
a series of compounds that structurally mimic FBP and incorporate a chromophore. These 
compounds should be capable of being cleaved by Class II FBP aldolases into the corresponding 
aldehyde (G3P mimicking or equivalent) and ketone (DHAP mimicking or equivalent) products 
leading to a distinguishable change in absorbance.  
 
Interestingly, aldolases possess high specificity towards their respective donor substrates and 
generally will not accept other donors, even if they are structurally similar to the natural ones (3). 
Thus, aldolases can be classified based upon this restricted donor specificity, such as DHAP-
dependent aldolases, pyruvate-dependent aldolases and acetaldehyde-dependent aldolases. FBP 
aldolases, together with rhamnulose 1-phosphate aldolase and tagatose 1,6-bisphosphate aldolase, 
all belong to the DHAP-dependent aldolases (3).  Whitesides and coworkers (4) first reported  
that permissive variations of the DHAP moiety are highly restricted in rabbit muscle aldolases (a 
Class I FBP aldolase) with only two exceptions out of 11 DHAP analogues, 1,3-dihydroxy-2-
butanone-3-phosphate and 1,4-dihydroxy-3-butanone-1-phosphate. Subsequently, Wong and 
coworkers (5) found that E. coli FBP aldolase (a Class II FBP aldolase) possessed the same 
donor substrate specificity as the rabbit muscle aldolase. In contrast to the strict donor substrate 
specificity, DHAP dependent aldolases accept a broad range of aldehyde substrates, such as 
unhindered aliphatic aldehydes, α-heteroatom substituted aldehydes, monosaccharides and their 
derivatives. Nevertheless, aromatic aldehydes, sterically hindered aldehydes and α,β-unsaturated 
aldehydes are generally not well accepted in the direction of aldol condensation (6). The DHAP 
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moiety is more important for immediate substrate recognition and binding from the perspective 
of retro-aldol direction compared to the G3P moiety of FBP aldolases. Therefore, it is crucial to 
retain DHAP as the donor substrate and only modify the acceptor aldehyde G3P to become 
chromogenic when designing a synthetic route to harvest the corresponding chromogenic 
substrate. 
 
Chromogenic substrates bearing chromophores generally consist of conjugated π-systems. In 
this system, mostly in aromatic systems, the lowest electronic energy transition occurs when a π-
electron is promoted from the highest occupied π molecular orbital to the lowest unoccupied π* 
molecular orbital, hence giving the absorption that can be detected spectrophotometrically (7). 
Therefore, it is reasonable to examine and screen different aromatic aldehydes as generalized in 



















aromatic                                                                                                              chromogenic 
aldehyde                                  DHAP                                                                 substrate
 
Scheme 2-2. The general approach to synthesize chromogenic substrates from aromatic 
aldehydes and DHAP. R group represents any substituent at either available ortho, meta or para 
position. 
 
conveniently detected in the near ultraviolet region with UV spectroscopy. The essential theory 
supporting this specific chromogenic assay is based upon the bathochromic shift effect, which is 
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the shift of absorption of chromophores to a longer wavelength due to substitution or solvent 
effect. Conversely, a hypsochromic shift is the shift of absorption to a shorter wavelength due to 
substitution or solvent effect (8).  
 
Specifically, the degree of conjugation of the substituents on the aromatic ring is different 
when comparing the aromatic aldehydes with FBP-mimicking chromogenic substrates. The π-
bond of the carbonyl contributes to a higher degree of conjugation for the aromatic aldehyde than 
does the hydroxyl group in proximity to the benzene ring for the chromogenic substrate; hence 
producing a bathochromic shift which can be distinguished by UV spectroscopy when the 
chromogenic substrate is cleaved into the corresponding DHAP and aldehyde products by Class 
II FBP aldolases. Moreover, other substituents on aromatic aldehydes will contribute to the 
bathochromic shift in different degrees when various electron donating groups or electron 
withdrawing groups are attached to para, meta and ortho positions accordingly (8). Thus, 
aromatic aldehydes with different substituents should be screened to find a group of promising 
candidates, which would give pronounced bathochromic shift when they are applied to 
chromogenic assay development. Subsequently, good candidates would be further modeled as 
corresponding FBP mimics to examine if they would fit the active site of FBP aldolases. 
However, at this stage, a synthetic difficulty emerges as previously mentioned, that aromatic 
aldehydes are generally not well accepted by DHAP-dependent aldolases in the direction of aldol 
condensation. This eliminated the possibility of applying aldolases as catalysts to synthesize the 
chromogenic substrates, which forced us to pursue an alternative non-enzymatic organic catalyst 
to accomplish the synthetic goal.  
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2.3 Direct asymmetric aldol reactions catalyzed by organocatalysts 
Based on excellent stereocontrol of asymmetric aldolizations catalyzed by aldolases, chemists 
have been pursuing simple organocatalysts that possess a similar function in formation of C-C 
bonds through aldol reactions. The organocatalysts were expected to act as either Class I aldolase 
with enamine based mechanism, or Class II aldolase with Lewis acidic metal and enolate based 
mechanism.  
 
 The first small molecule asymmetric Class II aldolase mimic was synthesized and reported by 
Nakagawa et al. (9) in the form of zinc, lanthanum and barium complexes. However, an 
enamine-based asymmetric Class I aldolase mimic was not described in the literature until 2000 
by List et al. (10). The authors found the amino acid L-proline, which works as an aldolase 
mimic, to be an effective asymmetric catalyst for direct aldol reaction between unmodified 
acetone and a variety of aldehydes (Scheme 2-3). They demonstrated a reaction between acetone 
and 4- nitrobenzaldehyde catalyzed by L-proline (30 mol%) and the corresponding aldol product 
was produced in a good yield (68%) and enantiomeric excess (76% ee). As a catalyst, proline is 
non-toxic, inexpensive, and readily available in both enantiomeric forms. Moreover, reactions 
































Within the same year, the same research group found L-proline was also able to catalyzed the 
direct aldol reaction between unprotected hydroxyacetone and various aldehydes to yield anti-
diols with excellent diastereoselectivity and enantioselectivity (Scheme 2-4) (11). Further 
research by Barbas and coworkers (12) proposed that the key step in the mechanism of direct 
asymmetric aldol reaction catalyzed by L-proline was the formation of the enamine intermediate 
between L-proline and the corresponding ketone donor substrate. The carbonyl group of the 
aldehyde acceptor was then attacked by the enamine intermediate with high enantiofacial 
selectivity. This was imposed by a highly organized tricyclic hydrogen bonded framework 
resembling a metal-free Zimmerman-Traxler type transition-state (Scheme 2-5), which is a 
model of the aldol reaction that describes a chair conformation of six-membered transition-states 
(13). Based on the Zimmerman-Traxler model, E-enolates from ketone donors give rise to anti-
products, whereas Z-enolates give rise to syn-products (14). Therefore, the mechanism proposed 
by Barbas and coworkers could assist us in understanding the rationale of the excellent 
diastereoselectivity and enantioselectivity of direct asymmetric aldol reactions catalyzed by L-








































































Scheme 2-5. Schematic representation of the Zimmerman-Traxler model. According to this 
model of the transition states of aldol reaction, E-enolates give anti products, whereas Z-enolates 
give syn products (M = metal, X = halide) (14).  
 
Bearing excellent stereocontrol as a catalyst for a variety of substrates for direct asymmetric 
aldol reactions, proline and its derivatives have been extensively explored for organic synthesis. 
However, the reactivity and selectivity of certain proline-catalyzed aldol reactions still have 
limitations since it is relatively difficult to structurally modify proline. Furthermore, proline is 
known to react with electron-deficient aromatic aldehydes to form iminium salts, which then 
undergo decarboxylation even at room temperature, and subsequently induce significant 
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retardation of the aldol reactions (15). Moreover, direct asymmetric aldol reactions catalyzed by 
proline would preferentially yield anti-diol product; whereas the 3-hydroxyl and 4-hydroxyl 
groups of the FBP-mimicking chromogenic substrates that are being pursued and also FBP itself 
are desired to be in syn-3S,4R configuration. Therefore, proline as a sole catalyst cannot provide 
the optimal route to the aldol reactions between dihydroxyacetone (DHA) and aromatic 
aldehydes with the proper stereoconfigurations as demanded.  
 
To achieve good yields and high diastereomeric and enantiomeric selectivity for catalyzed 
direct asymmetric aldol reactions by organocatalysts or Lewis acidic metal complexes, 
anhydrous organic solvents are often required. Recently, zinc complexes of proline, lysine and 
arginine were found to be efficient catalysts for aldol reactions of 4-nitrobenzaldehyde and 
acetone in aqueous media at room temperature with good yield and enantioselectivity (16). 
Furthermore, zinc-proline complex in the form of Zn(Pro)2 was also reported to be able to 
catalyze aldol reactions between DHA and various aromatic aldehydes such as 4-
nitrobenzaldehyde, 2-nitrobenzaldehyde, and 2-bromobenzaldehyde with excellent yields in 
water with tetrahydrofuran as co-solvent (17). However, in contrast to the results obtained with 
proline as the catalyst, moderate syn-selectivities were observed instead of complete anti-
selectivities. Especially for the aldolization between DHA and 2-bromobenzaldehyde, the 
syn/anti ratio was found to be 3:1. Normally, a catalyst incorporating metal should act as a Lewis 
acid in water and in this respect Zn(Pro)2 could be considered as a Class II aldolase mimic, in 
which the zinc ion coordinates to the carbonyl to facilitate the enolate formation, whereas the 
proline ligand provides the chiral environment for enantioselectivity (17). Interestingly, further 
study by Kofoed et al. (18) suggested that Zn(Pro)2 complex uses both enolate and enamine 
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mechanisms in a substrate dependent manner. Specifically for acetone as the ketone donor, zinc 
ion was assumed to assist and stabilize the enamine intermediate formed between proline and 
acetone instead of a Lewis acid. The dual mechanism of Zn(Pro)2 complex was presumably 
attributed to the inductive effect by the OH groups of DHA which lower the pKa of the α-CH, 
and also to the stabilization of enolate formation by intramolecular hydrogen bonding.  
 
Although Zn(Pro)2 complex is able to catalyze the direct asymmetric aldolization between 
DHA and aromatic aldehydes in preference to our desired syn-adduct, the only low to moderate 
enantiomeric excess values from the authors prompted us to search for better amine catalysts that 















2.4 Simple primary amine organocatalysts 
In the previous section, direct asymmetric aldol reactions were demonstrated to be attainable 
through either metal-based catalysis, or highly enantioselective small molecule organocatalysts, 
such as proline and its derivatives. Noticeably, most of the presently available organocatalysts 
functioning via an enamine-based mechanism, such as proline and chiral pyrrolidine derivatives, 
are secondary amines (19). Therefore, it is of great interest for chemists to develop primary and 
tertiary amine catalysts to expand the utility of enamine-based organocatalysts.  
 
Recently, Cordova et al. (20) have shown examples of primary amine catalysts, that several 
acyclic amino acids such as alanine, valine, leucine, isoleucine and threonine were able to 
catalyze the direct asymmetric aldol reaction between cyclohexanone and  p-nitrobenzaldehyde 
with excellent enantioselectivities by 30 mol% catalyst injection in wet DMSO. Alanine was also 
shown by the authors to be able to catalyze the aldol reaction between cyclic protected DHA 
dimethyl-1,3-dioxan-5-one and p-nitrobenzaldehyde with promising 84% yield and greater than 
99% enantiomeric excess (Scheme 2-6). Moreover, Jiang et al. (21) also found tryptophan to be 


















enantioselectively in water. Interestingly, secondary amine catalysts such as proline and chiral 
pyrrolidine derivatives can only provide access to anti-configured 1,2-diols. These catalysts 
mimic the activity of D-tagatose-1,6-diphosphate and L-fuculose-1-phosphate aldolases, which 
only utilize anti-configured 1,2-diols as substrates. However, access to syn-configured 1,2-diols 
by using organocatalysts and DHA-based strategy had been not available until Ramasastry et al. 
(22) published the first syn-selective aldol reactions between unmodified hydroxyacetone and 
aromatic aldehydes by using several unmodified and modified acyclic amino acids such as L-
tryptophan, L-threonine, O-tBu-L-threonine and O-tBu-L-tyrosine. Compared to the secondary 
amines, these primary amines functionally mimic the activity of L-rhamnulose-1-phosphate and 
FBP aldolases, which only utilize syn-configured 1,2-diols as substrates. 
 
Ramasastry et al. not only demonstrated the first syn-selective direct asymmetric aldol 
reactions by using primary amine catalysts, but also elegantly explained the mechanism behind 
the rather different syn- or anti-selectivities when using primary amine or secondary amine 
catalysts, respectively (22). The authors reasoned that, in the reactions of hydroxyacetone with 
proline as a catalyst, aldol products form via reactions involving an E-enamine intermediate B as 
shown in Scheme 2-7. For pyrrolidine-derived catalysts or other secondary amines, E-enamine 
intermediates B predominate over the Z-enamine intermediate A, due to the steric effect between 
the hydroxyl group and the pyrrolidine ring in intermediate A. The anti-configuration of products 
was attributed to the transition state C in Scheme 2-7, since it is the Si-face of the E-enamine that 
reacts with the incoming aldehyde acceptor. Similarly, the authors suggested that Z-enamine 
intermediate F should predominate in the reaction of hydroxyacetone with primary amine 
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Scheme 2-7. Schematic representation of the mechanisms explaining anti- and syn-selectivities 
of secondary amine and primary amine catalysts, respectively. (a) Possible Z- and E-enamine 
intermediates formed between hydroxyacetone and secondary amine catalyst proline (A and B), 
transition state with the aldehyde acceptor (C), and the corresponding anti-aldol product (D). (b) 
Possible E- and Z-enamine intermediates formed between hydroxyacetone and primary amine 
catalyst (E and F), transition state with the aldehyde acceptor (G), and the corresponding syn-
aldol product (H) (22).  
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Moreover, during their early studies of aldol reactions involving unmodified hydroxyacetone 
mediated by antibody catalysis, the Z-enamine intermediate was observed to form with the  
primary amine lysine side chain, the key catalytic residue in aldolases. The syn-configuration of 
products could be attributed to the transition state G in Scheme 2-7, which promotes the 
formation of syn-aldols (22).  
 
Interestingly, Barbas and coworkers (23, 24) recently reported syn-selective direct asymmetric 
aldol reactions between unprotected and protected DHA with aromatic aldehydes catalyzed by 
primary amine catalysts. They successfully demonstrated that syn-configured aldol product can 
be obtained from unprotected DHA and p-nitrobenzaldehyde with either a 3R,4S or 3S,4R 
absolute configuration when catalyzed by O-tBu-L-threonine, which functionally mimics L-
rhamnulose-1-phosphate aldolase; or by O-tBu-D-threonine, which functionally mimics FBP 
aldolases, respectively (23). The authors also showed that the same catalysts are able to catalyze 
syn-selective aldol reactions of tert-butyldimethylsilyl or benzyl protected DHA with 
corresponding aromatic or aliphatic aldehydes (24).  
 
Markert et al. (25) have recently found a remarkable catalytic effect of tertiary amines in aldol 
reactions of unprotected DHA with certain aldehydes. They reported that 10 mol% diazabicyclo-
undec-7-ene (DBU) or 30 mol% cinchonine with Dowex could mediate syn-selective aldol 
reactions just as their primary amine catalyst counterparts. However, the authors suggested that 
the mechanism of aldol reactions mediated by tertiary amine cannot be compared with the 
reactions catalyzed by primary or secondary amine catalysts, thus, further investigations are still 
currently underway. 
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2.5 Chiral primary-tertiary diamine-Brønsted acid catalyst 
Simple primary or secondary amino acids and their derivatives were surveyed and shown to be 
stereoselective catalysts for direct aldol reactions in the previous sections. However, the 
relatively low efficiency (20-30 mol% loading) and non-broad substrate scope of these amine 
catalysts may preclude them from large scale and more general applications.  
 
As mentioned previously, secondary amine catalysts such as proline and chiral pyrrolidine 
derivatives could only provide access to anti-configured 1,2-diols, and reactions are mainly 
limited to cyclic protected DHAs. Similarly, primary amine catalysts such as threonine and its 
derivatives could only catalyze syn-aldol reactions of hydroxyketones, or DHA and acyclic 
protected DHAs, respectively. Interestingly, a significant advance has been accomplished by the 
very recent work of Luo et al. (26, 27). The authors published the first example of chiral 
primary-tertiary diamine-Brønsted acid catalysts. Trans-N,N-dialkylated-diaminocyclohexanes 
(Figure 2-1) with a strong acidic additive, were reported to catalyze both syn- and anti-aldol 
reactions of unprotected and cyclic protected DHAs with high yields and excellent 
stereoselectivity. Such primary amines can functionally imitate all of the four types of DHAP-
dependent aldolases, namely L-rhamnulose-1-phosphate and FBP aldolases (syn-aldol products), 







Figure 2-1. Structure of trans-N,N-dialkylated-diaminocyclohexane. 
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Noticeably, the authors first found the activity and stereoselectivity of chiral trans-N,N-
dimethyldiaminocyclohexane to be superior to other primary amine catalysts when it was used to 
catalyze direct aldol reactions of acetone and other small aliphatic ketone donors (26). Further 
screening of the analogous catalysts of trans-N,N-dimethyldiaminocyclohexane bearing longer 
alkyl chains demonstrated improved yields and stereoselectivity, with acyclic DHA derivatives 
including free DHA as ketone donors (27). The best results were obtained with trans-N,N-








Figure 2-2. Structures of trans-N,N-dialkylated-diaminocyclohexane derivatives.  
 
 
Importantly, the strong Brønsted acid trifluoromethane sulfonic acid (TfOH) was demonstrated 
to be essential for the catalysis, as the reaction in absence of TfOH was observed to give less 
than 10% yield and poor stereoselectivity. The authors suggested that protonation on the tertiary 
amine moiety of the catalyst by TfOH rendered it a direct hydrogen bonding donor as shown in 
Scheme 2-8. Furthermore, the syn stereoselectivity towards acyclic DHA derivatives could be 
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explained by a Z-enamine transition state a as the model proposed in Scheme 2-8, which is 
consistent with the model presented by Ramasastry et al. in the previous section (22). In contrast, 
the reactions of cyclic DHA derivatives, which are only capable of forming E-enamine 










































Scheme 2-8. Proposed transition states and corresponding products of aldol reactions of acyclic 
and cyclic DHA derivatives catalyzed by primary-tertiary diamine-Brønsted acid catalysts. This 
scheme was adapted from Luo et al. (27).  
 
 
Furthermore, the authors also reported that addition of a second weak Brønsted acid such as 
m-nitrobenzoic acid did further improve the yield. Moreover, in their early experiments, it was 
found that the loading of the catalyst could be reduced to as low as 2 mol% in certain conditions, 
while still maintaining good enantioselectivity and significant activity by adding this weak acid. 
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This weak Brønsted acid was proposed to facilitate the enamine catalytic cycle and to increase 
the yield of products, but the detailed mechanism is still unknown (26, 28).  
 
     In summary, under optimal experimental conditions, the best results as reported by the 
authors were up to 97% yield, 99:1 syn:anti ratio and 99% enantiomeric excess by using these 
chiral primary-tertiary diamine-Brønsted acid catalysts from DHA and its derivatives. Therefore, 
this was viewed as the best strategy for us to follow in synthesis of the unphosphorylated version 

















2.6 Application of a phosphate ester mimic in the chromogenic assay 
The desired chromogenic substrates can be synthesized from DHA and aromatic aldehydes 
through direct asymmetric aldol reactions catalyzed by the chiral primary-tertiary diamine-
Brønsted acid catalysts presented in the previous section; however, the problem of 
phosphorylation on the DHA moiety still remains unsolved. Recall the fact that DHAP-
dependent Class II FBP aldolases possess strict donor substrate specificity towards DHAP. Since 
the phosphate moiety of DHAP is responsible of forming hydrogen bonds with four residues in 
the enzymatic active site, this factor has become the major determinant for binding affinity 
between Class II FBP aldolases and DHAP (29). Therefore, it is crucial to develop a proper 
strategy of phosphorylation on the DHA moiety to create the chromogenic substrates which will 
be subjected to the actual chromogenic assay.  
 
In their publication, Ma et al. (30) described an experimental method to chemically 
phosphorylate the primary hydroxyl group of aromatic ketal alcohols, by simply mixing diethyl 


















Free phosphates can be obtained by subsequent hydrolysis of the phosphate esters. However, it is 
possible for the phosphorylating agent to perform non-selective phosphorylation on the 
secondary 3- or 4-hydroxyl groups on the chromogenic substrate. Furthermore, the secondary 
hydroxyl groups may also nucleophilically attack the phosphate ester and lead to formation of 
ring structured compound even if the phosphorylating agent could selectively phosphorylate the 
primary hydroxyl group on the chromogenic substrate.  
 
Interestingly, it has been reported that inorganic arsenate and vanadate are able to form 
arsenate and vanadate esters with free DHA in situ, which act as phosphate ester mimics in 
practical enzymatic aldol reactions (31, 32). Wong and cowokers (31) first demonstrated that 
DHA in the presence of a catalytic amount of arsenate and vanadate was an effective substrate 
for FBP aldolases. Unlike phosphate esters, the arsenate and vanadate esters were formed 
spontaneously and reversibly in aqueous solution. This makes it feasible to perform enzymatic 
reactions with a mixture of inorganic arsenate or vanadate and the unphosphorylated organic 
alcohol products to replace the corresponding organic phosphate, which is naturally the substrate. 
Nevertheless, the high toxicity of arsenate could be problematic from a practical point of view. 
Although vanadate can be utilized even at lower concentration, its redox activity, instability and 
its high cost would limit its practical application.  
 
To circumvent the drawback of arsenate and vanadate, Wong and coworkers (29) found that 
inorganic borate also allows DHA to be accepted as a substrate by rhamnulose 1-phosphate 
aldolase (RhaD), presumably by reversibly forming a borate ester with DHA in situ (Scheme 2-


















R = OH (L-fructose)




utility to be used as a phosphate ester mimic. Noticeably, when the borate concentration was in 
4-fold excess of the DHA concentration, the maximum yield of aldol product was obtained by 
the authors. It was proposed that excess borate may play a role in trapping the aldol product and 
preventing the reverse reaction.  
 
Therefore, inorganic borate can be utilized to form a borate ester with our chromogenic 
substrate once it has been synthesized, acting as a phosphate ester mimic, which presumably will 
be accepted by Class II FBP aldolases in the chromogenic assay as we have planned. The borate 
concentration will also be controlled to facilitate the retro-aldol cleavage of the FBP mimicking 







2.7 Results and Discussion 
 
UV-visible spectrophotometric assay 
    Two aromatic model compounds, 5-nitro-furaldehyde (represents the aromatic aldehyde) and 
5-nitro-furfuryl alcohol (represents the chromophore moiety of the FBP-mimicking chromogenic 
substrate) were examined by UV-visible spectrometry to determine if there was an adequate 






























of the retro-aldol reaction, in order to ensure the feasibility of the direct chromogenic assay 
(Scheme 2-11). This was done by screening the maximum absorbance and the corresponding 5-
nitro-furaldehyde was found to be 0.794 O.D. at 313 nm, and the maximum absorbance of 5-
nitro-furfuryl alcohol was found to be 0.551 O.D. at 322 nm, with a final concentration of 50 μM 























Figure 2-3. Scanning of two model compounds by UV-visible spectrometry. Solutions of two 
model compounds 5-nitrofuraldehyde and 5-nitro-furfuryl alcohol in DMSO and KH2PO4 buffer, 
were scanned from 200 nm up to 600 nm by UV-visible spectrometry to determine the maximum 
absorbance and corresponding wavelength. Only the region from 270 nm to 380 nm and 
selective data points were shown in the figure.  
 
 
compounds were calculated to be 6440 cm-1M-1 at 307 nm, apparently can be distinguished by 
UV-visible spectrometry. However, different aromatic aldehydes and corresponding 
chromogenic substrates would produce different Δε values, which could be potentially higher or 
lower compared to the value obtained by the aforementioned model compounds. Further 
screening of compounds by UV-visible spectrometry will be demanded to confirm this.   
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    Although the data look promising, the feasibility of direct chromogenic assay in examining the 
enzyme activity of Class II FBP aldolases still demands further testing. Since it is still unknown 
if the chromogenic substrates would be accepted by Class II FBP aldolases until the synthesis of 
those compounds are completed, which will be subjected to kinetic assay subsequently.  
Compared to the Δε value between NAD+ and NADH (10680 cm-1M-1) used in the coupled-
enzymatic assay (33), Δε of the two model compounds is approximately 2 times smaller, 
indicating the sensitivity of the direct chromogenic assay could be lower. Noticeably, in the 
coupled-enzymatic assay, the presence of the coupled enzyme TIM prompts the conversion from 
one G3P to one DHAP, hence doubles the apparent concentration of DHAP, which will then 
increase the sensitivity of this coupled assay.  
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Synthesis of FBP-mimicking chromogenic substrate 
The method chosen for synthesis of the potential chromogenic substrates for FBP aldolases is 
based on the work published recently by Luo and coworkers (27). It has been reported that the 
asymmetric aldol condensation of dihydroxyacetone (DHA) with various aromatic aldehydes can 
be accomplished at room temperature employing a catalyst derived from optically pure trans-1,2-
diaminocyclohexane as described earlier (see page 35). The version of the catalyst that is 







Figure 2-4. Structure of the chiral primary-tertiary diamine-Brønsted acid catalyst for 
preparation of FBP-mimicking chromogenic substrate. 
 
The synthesis of this catalyst is based on a procedure developed earlier by the same group (26).  
The method involves the mono-N-acetylated version of the C2-symmetric diamine by reaction 
with the hydrochloride salt of ethyl acetimidate as originally described by Mitchell and Finney 
(34). The acetylation process is thought to first yield the imidazoline 2-2 which is then 
hydrolyzed to the mono-N-acetylated product 2-3 (Scheme 2-12). In the published experimental 
procedure, the ethyl acetimidate salt was first generated in situ by reaction of two equivalents of 
acetonitrile with HCl gas in dry ethanol, followed by addition of one equivalent of the diamine 
compound. In the present study, it was found that the acetimidate salt was commercially 
available and thus the diamine was added to 2.8 equivalents of the commercial material in dry 
ethanol. 
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However, the product obtained in this reaction was found to contain an impurity. The 1H NMR 
spectrum of the crude product exhibited two singlets assignable as N-acetyl groups at δ = 2.14 
and 2.11 ppm. 1H-1H homonuclear correlation spectroscopy (COSY) NMR analysis revealed a 
correlation between two complex multiplets of equal intensity at δ = 3.35 and 2.32 ppm that were 
reasonably assigned to C1-H and C2-H signals of the desired product. In addition, there is a 
simpler multiplet at δ = 3.57 ppm which seemed to be consistent with a signal expected for the 
N,N-diacetyl derivative 2-4 which has a C2 symmetry (Figure 2-5). ESI-MS analysis of the 
mixture also provided support for the suggestion that the impurity was the diacetylated material 












Figure 2-5. Structure of the diacetylated impurity 2-4.  
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Furthermore, a peak found at m/z = 157 is consistent with the (M+H+) fragment for the desired 
monoacetylated compound. Also, the 13C JMOD NMR spectrum offered further evidence to 
support this conclusion. The asymmetrical monoacetylated product was expected to provide 8 
signals (5 phased up and 3 down), whereas the C2-symmetric diacetylated product would give 
rise to 5 signals (3 phased up and 2 down). Observation from the full JMOD spectrum provided 
13 signals in total (8 phased up and 5 down), which is consistent with expected distribution 
pattern of a mixture of these two compounds.  
 
    Once the nature of the impurity was recognized, it was decided that separation of the desired 
monoacetylated product 2-3 from the diacetylated byproduct 2-4 might be accomplished by 
taking advantage of the basicity of the former compound. Thus, the mixture was treated with 
excess amount of commercial solution of 1.25 M HCl in ethanol followed by evaporation of 
solvent to provide a mixture of the diacetylated compound and the solid hydrochloride salt of the 
monoacetylated compound. The solid mixture was then triturated successfully with multiple 
portions of diethyl ether, acetonitrile and ethyl acetate, with the progress of the separation being 
monitored by NMR analysis of the solid residue. In the 500 MHz 1H NMR spectrum of the solid 
hydrochloride salt of 2-3,  the NH3+ protons appear as a singlet at δ = 7.88 ppm partially 
overlapped with a one hydrogen doublet (δ = 7.93 ppm, J = 8.5 Hz) corresponding to the amide 
proton of the protonated target molecule. The signal assignable to the amide NH of the impurity 
is at 7.55 ppm and the relative intensity suggests that the catalyst precursor contained 
approximately 15% of the impurity. This separation process reduced the quantity of the 
diacetylated byproduct sufficiently so that the material could be used at later stage in attempts at 
the catalytic asymmetric aldol condensation reaction between DHA and aromatic aldehydes. 
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The free base form of 2-3 was produced form the salt using sodium hydroxide solution.  The 
use of this material in asymmetric aldol reactions is described later. While asymmetric aldol 
reaction were explored with this small amount of catalyst precursor, additional work was carried 
towards improving the preparation of the catalyst but using the much less expensive racemic 
form of trans-1,2-diaminocyclohexane. The primary concern was to work out the conditions that 
would avoid the formation of the diacetylated byproduct which was not obtained in the original 
literature report. Compared to the conditions used in the present study with those used in the 
original literature report, it was noted that our study employed 2.8 equivalents of preformed ethyl 
acetimidate salt with the diamine precursor; whereas the literature method involved generation of 
the acetimidate in situ from two equivalents of acetonitrile. Thus it was reasoned that in the 
previously reported method the formation of the acetimidate may have been incomplete when the 
reaction with the diamine was done, so that only approximately one equivalent of the acetimidate 
salt might have been present; whereas in our work, we employed two full equivalents of the 
preformed salt. With only one equivalent of acetimidate, the initial product cyclizes to the 
imidizolium salt that yields a monoacetylation product upon hydrolysis. In our work it appears 
that there is a considerable competition between cyclization of the initial product and reaction of 
the second amino group with a second molecule of the aceimidate, leading eventually to the 




























With the racemic diamine, and with only one equivalent of the acetimidate salt, it proved to be 
possible to get a good yield of the monoacetylated diamine. The reductive amination of the free 
amino group in the monoacetylated diamine was found to proceed well in both the chiral system 
on a small scale, and in the racemic series on a substantially larger scale (Scheme 2-14). After 
hydrolysis of the amide, N,N-di-n-propyl-trans-1,2-diaminocyclohexane (2-5) was afforded that 
would be used in catalyst preparation. In the case of the racemic material, it was possible to 
obtain the product in a very high state of purity by vacuum distillation, which was not feasible in 
the enantio-pure series because of the small scale of that preparation. Comparison of the proton 
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spectrum of the same material as reported in the literature reveals that a number of the signals in 
the reported spectrum actually arise from impurities that were not identified nor even recognized 
as being present. The catalyst system is prepared by reaction of 2-5 with trifluoromethane 
sulfonic acid to form the triflate salt of this compound. The N-protonated system plays a key role 
in the asymmetric induction seen in the aldol condensation as described earlier. 
 
Our first experiments with the catalyst system involved the chiral version of 2-5 which was 
produced only in very small amount, thus reactions were done on a relatively small scale. Since 
trifluoromethane sulfonic acid is moderately expensive and highly reactive and corrosive, we 
were reluctant to make the triflate salt of the small amount of the chiral catalyst. This is because 
it would lead to loss of much of the triflic acid once the seal on the glass ampule in which it is 
sold was broken since triflic acid reacts violently with even traces of moisture. Therefore, it was 
decided that the chiral material would be reacted instead with methane sulfonic acid which is 
much more readily handled. Thus a solution of the methane sulfonic acid salt of the chiral 























Following the literature procedure (Scheme 2-15), except for use of the methane sulfonic acid 
salt (10 mol%) form of the catalyst rather that the triflic acid salt, including the use of m-
nitrobenzoic acid as an additive, a crude DMF solution containing the product was obtained and 
which was passed through a silica gel column to remove much of the DMF and some unreacted 
starting materials. 1H NMR analysis of the product at this stage revealed the presence of the 
desired product as indicated by signals at δ = 5.22, 4.55 and 4.30 ppm as reported in the literature 
but also a comparable amount of unreacted p-nitrobenzaldehyde. A relatively pure sample of the 
target compound 2-6 was then obtained by trituration with dichloromethane which removed the 
unreacted aldehyde and residual DMF. The 1H NMR spectrum in methanol-d4 solution of the 
purified product 2-6 showed the expected AA'BB' system (Figure 2-6) as an apparent set of two 
doublets and signals from the two C-H and the CH2 group. The two C-H groups appear to be 
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mutually coupled but with a surprisingly small coupling constant of about 2 Hz.  The CH2 group 
appears, deceptively, to be a doublet with a coupling constant of 0.6 Hz. In reality it is likely that 
this signal corresponds to a collapsed AB system with very weak outer lines and the line 
separation indicated above is not actually a coupling constant. Also, an impurity that gives rise to 
a singlet at δ = 4.28 ppm is also present, but the structure of the impurity is as yet unknown. In 
addition, the JMOD 13C NMR spectrum of this material exhibited signals that were very similar 
















HBJ = 2 Hz
 
Figure 2-6. Schematic representation of the AA'BB' system of 2-6. 
 
This product 2-6 was available in sufficient amount to allow for just one attempt at the 
introduction of the phosphate group. Reaction of this compound with diphenyl chlorophosphate 
provided a crude product which appeared to contain only one phenyl group as indicated by the 
ratio of the intensity of signals from the phenyl group and those from the p-nitroaryl group.  One 
possibility is that the initially formed phosphate derivative has undergone an intramolecular 
reaction to form a cyclic phosphate derivative 2-7 with the expulsion of a molecule of phenol 
(Scheme 2-16). If this is the case, then it is unlikely that this approach will allow us to prepare 





















    In the racemic catalyst preparation, the amount of material which was prepared was large 
enough that it was reasonable to make the triflic acid salt form of the catalyst. Noticeably, the 
dispensing of the triflic acid was accompanied by extreme fuming, thus it is much less 
convenient than forming the methane sulfonic acid salt. Since there is no report of the 
spectroscopic characteristics of this triflic acid salt of the catalyst, the 1H NMR spectrum is 










2.8 Future work 
Since a substantial quantity of the racemic form of the triflic acid salt of the catalyst is now 
available, it is recommended that this to be used to make the racemic version of the aldol adducts 
with a variety of aromatic aldehydes including 5-nitrofuraldehyde. Since the 
monophosphorylation strategy appears to be problematic, it is suggested that the introduction of 
a phosphate group onto 2-6 should be avoided and that the alcohol form of the aldol products be 
used in the presence of borate to form the boric acid adducts, as mimics of the phosphate in situ 
in the chromogenic assay mixture (Scheme 2-17). Additionally, it is suggested that the racemic 
aldol products to be evaluated in the assay and that the most promising one of these compounds 






















2.9 Experimental  
 
General experimental  
All the reagents used were purchased from Sigma-Aldrich or from Lancaster Synthesis unless 
otherwise stated. All reactions were performed either under an argon or nitrogen atmosphere and   
monitored by thin layer chromatography (TLC) using aluminum-backed sheets precoated with 
silica gel (0.2 mm) (EMD Chemical Inc.). TLC plates were analyzed by an ultraviolet lamp (254 
nm). Anhydrous solvents were obtained from the Manual Solvent Purification System (M. Braun 
Inc.). Flash column chromatography was performed using silica gel (230-400 mesh). The UV-
visible assay was performed with Cary 100 UV-visible spectrometer (Version 8.01, Varian). The 
low resolution electron impact (EI), chemical ionization (CI) and electrospray (ESI) mass spectra 
were obtained by Dr. Richard Smith at the University of Waterloo. 1H NMR and 13C NMR (J-
MOD) spectra were obtained on a Bruker Avance-300 (300 MHz) or Avance-500 (500 MHz) 
NMR spectrometer with d-chloroform, d4-methanol or d6-dimethyl sulfoxide as the solvent. 
 
UV-visible spectrophotometric assay 
Each of 5-nitro-furaldehyde (0.10 mmol) and 5-nitro-furfuryl alcohol (0.10 mmol) was 
dissolved in 0.10 mL of DMSO to make 1.0 M stock solution of the compound, respectively. To 
make one standard UV-visible assay mixture, 1.0 µL of the compound solution was transferred 
into 199 mL of DMSO to prepare a 1/200 diluted sample. Then 10 mL of the diluted sample was 
transferred as an aliquot into 990 mL of 50 mM prepared KH2PO4 buffer to make a 1 mL assay 
mixture with final concentration of 50 μM and 1% v/v DMSO. The 1 mL assay mixture was then 
completely transferred into a UV-compatible cuvette (VMR, 1 cm path length) and scanned with 
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Cary 100 spectrometer (Varian) from 600 nm down to 200 nm with a 1 nm interval at room 
temperature for each model compound.  
 





















This experimental procedure was adapted from Mitchell and Finney (34). The reaction was 
first performed with optically active (-)-enantiomer of 2-1. In a 25 mL round-bottomed flask, 
ethyl acetimidate hydrochloride (1.09 g, 8.81 mmol, 2.8 equiv) was dissolved in 5 mL of dry 
ethanol, and the reaction flask was then transferred to 0 °C bath under an N2 atmosphere. Then 
the optical active enantiomer of 2-1 (0.35 g, 3.02 mmol, 1.0 equiv) was added to the flask and 
the reaction mixture was allowed to stir overnight at room temperature. The reaction mixture was 
then quenched with 40 mL of 1.0 M NaOH and extracted three times with 50 mL of 5% 
MeOH/CH2Cl2. The combined organic layers where dried over anhydrous Na2SO4 and 
concentrated in vacuo to afford 0.43 g of crude product 2-2. The crude product was refluxed in 
30 mL of ethanol/H2O (1:1 v/v) overnight, then concentrated to afford 0.24 g of crude product 
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containing both the monoacetylated (2-3) and diacetylated compounds (2-4). To separate 2-3 
from 2-4, a solution of 1.25 M anhydrous HCl/ethanol (1.2 mL, 1.25 equiv) was added to this 
crude product and it was allowed to stir for 30 minutes at room temperature to convert 2-3 to its 
salt. The solvent in the solution was blown off under N2 to afford the solid and it was then 
triturated four times with 5.0 mL of diethyl ether, followed by 5.0 mL of acetonitrile, then three 
times with 5.0 mL of ethyl acetate to afford the salt of 2-3 (0.16 g). 1H NMR δ = 7.93 ppm (1H, 
d, J= 8.5 Hz, NHAc), 7.88 (3H, s, NH3+), 3.60 (1H, m; CHNHAc), 2.77 (1H, m, CHNH3+) 1.95-
1.98 (1H, m), 1,83 (3H, s, NHC(=O)CH3), 1.5-1.7 (approx. 3H, m), 1.10-1.34 (approx. 4H, m). 
The spectrum also shows signals from the N, N’-diacetyl impurity (approx. 15%) δ = 7.51 (br s, 
NHAc), 3.27 (m, CHNHAc), 1.72 (s, NHC(=O)CH3). Then 2-3 was liberated from its salt by 
adding 40 mL of 1.0 M NaOH, followed by extracting three times with 20 mL of 5% 
MeOH/CH2Cl2. The organic layers were combined and dried over anhydrous Na2SO4 and 
concentrated in vacuo to afford relatively pure 2-3 (0.08 g). 1H NMR (300 MHz) δ = 6.14 (1H, 
br s, NHAc), 3.49 (1H, br, CHNHAc), 2.40 (1H, br), 2.02 (3H, s, NHCH3), 1.15-1.73 (approx. 
8H, m). Signals from the N, N’-diacetylated product are also present (approx. 12%). 13C J-MOD 
δ = 170.3 (up), 56.0 (down), 55.2 (up), 53.6 (down), 35.3 (up), 25.0 (up), 23.4 (down).  Signals 
from the N, N’-diacetylated impurity are also present at δ = 170.1 (up), 55.2 (down), 32.1 (up), 
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2-3                                                                                          2-5
 
 
This experimental procedure was adapted from Luo et al. (26). In a 25 mL round-bottomed 
flask, 2-3 (0.08 g, 0.46 mmol, 1.0 equiv) was dissolved with 5.0 mL of acetonitrile, followed by 
0.2 mL of distilled water and 0.2 mL of propionaldehyde (2.28 mmol, 5.0 equiv) and stirred for 
15 min under an N2 atmosphere at room temperature. Then an aliquot of 1.0 M NaCNBH3 
solution in THF (0.96 mL, 0.96 mmol, 2.1 equiv) were delivered into the reaction mixture slowly 
via syringe and it was allowed to stir for 15 min under N2 at room temperature. Then 0.2 mL of 
glacial acetic acid was added to the flask and the reaction was allowed to proceed for 2 hours 
under N2 at room temperature. The volatiles were removed in vacuo and the crude product was 
taken up in 20 mL of ethyl acetate and 5.0 mL of 1.0 M NaOH, then washed three times with 5.0 
mL of 1.0 M NaOH and 5.0 mL of brine. The organic layer was dried over anhydrous Na2SO4 
and concentrated in vacuo. The crude product was then taken up in 15 mL of 4.0 M aqueous HCl 
and refluxed overnight under N2. The reaction mixture was cooled to room temperature and the 
pH was adjusted to approximately 13 with 20 mL of 4.0 M NaOH. The aqueous solution was 
extracted three times with 40 mL of and CH2Cl2, dried over anhydrous Na2SO4 and concentrated 
in vacuo to afford 0.04 g of the crude product 2-5. 1H NMR δ = 0.89 ppm (6H, t, J = 7 Hz), 2.48-
2.53 (1H, m), 2.25-2.45 (4H, m), 1.0-2.2 (complex overlapping multiplets). 
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This experimental procedure was adapted from Luo et al. (27). To make the catalyst stock 
solution (0.036 M), 2-5 (0.38 g, 0.19 mmol, 1.0 equiv) was dissolved with 2.0 mL of HPLC 
grade CH2Cl2 and transferred to a 5.0 mL volumetric flask. Due to the small scale of this reaction 
and the hygroscopic nature of trifluoromethanesulfonic acid, methanesulfonic acid (0.012 mL, 
0.18 mmol, 1.0 equiv) was used instead and transferred to the flask via a 100 mL-syringe. Then 
HPLC grade CH2Cl2 was added to fill up the rest volume and the solution was gently mixed. 
Then an aliquot of solution from the catalyst stock (1.2 mL, 0.043 mmol, 10 mol%) was 
transferred to a 5 mL round-bottomed flask and the catalyst was concentrated by blowing off the 
solvent under N2. DMF (400 mL) was added to the reaction flask followed by m-nitrobenzoic 
acid (8.0 mg, 0.043 mmol, 10 mol%), dihydroxyacetone (0.041 g, 0.23 mmol, 1.0 equiv, added 
as dimer) and 4-nitrobenzaldehyde (0.070 g, 0.46 mmol, 1.0 equiv). The reaction mixture was 
allowed to stir overnight under N2 at room temperature. The reaction was monitored by TLC 
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with isopropanol/hexane (3:7) and the spots of starting material were observed.  The crude 
product was just then purified by silica gel flash chromatography using the same solvent system 
as TLC and the fractions containing the desired product were combined, dried over anhydrous 
Na2SO4 and concentrated in vacuo to afford 0.012 g of the product. Results from 1H NMR 
indicated the presence of residual DMF in the product. Three portions of ethyl acetate (2.0 mL) 
were used to triturate the product and 0.010 g of the product 2-6 containing minor impurities 
were afforded. 1H NMR (methanol-d4) δ = 8.19 (2H) and 7.69 ppm (AA'XX', apparent doublets), 
5.22 (1H, d, J = 2 Hz), 4.55 (2H, likely collapsed AB system), 4.34 (1H, d, J = 2 Hz). 13C NMR 
J-MOD δ = 212.8 (up), 151.1 (up), 149.0 (up), 129.0 (down), 128.7 (up), 80.9 (down), 74.9 
(down), 68.5 (up). 
 
To examine the influence of the total amount of catalyst present in the reaction, 20 mol% 
injection and two times longer reaction time was used to repeat this reaction. An aliquot of 
solution from the catalyst stock (1.5 mL, 0.054 mmol, 20 mol%) was transferred to a 5 mL 
round-bottomed flask. The catalyst was concentrated by blowing off the solvent under N2. DMF 
(400 mL) was added to the reaction flask followed by m-nitrobenzoic acid (9.0 mg, 0.054 mmol, 
20 mol%), dihydroxyacetone (0.024 g, 0.14 mmol, 1.0 equiv, added as dimer) and 4-
nitrobenzaldehyde (0.041g, 0.27 mmol, 1.0 equiv). The reaction mixture was allowed to stir 
overnight under N2 at room temperature. The reaction was monitored by TLC with 
isopropanol/hexane (3:7) and the spots of starting material were observed. Results from 1H NMR 
did not indicate any significant improvement compared to the first trial of this reaction. The 






























This experimental procedure was adapted from Ma et al. (30). To make a 2.0 mL of the stock 
solution of the starting materials diphenylchlorophosphate (0.42 M), 0.17 mL of this compound 
(0.22 g, 0.84 mmol) was diluted in 1.83 mL of THF. To make a 5.0 mL of the stock solution of 
pyridine (0.63 M), 0.26 mL of pyridine (0.25g, 3.16 mmol) was diluted in 4.74 mL of THF. In a 
10 mL round-bottomed flask, 600 mL of dry THF was added to dissolve 2-6 (0.01 g, 0.042 mmol, 
1.0 equiv). An aliquot from the stock solution of pyridine (100 mL, 0.063 mmol, 1.5 equiv) was 
then transferred to the flask and the reaction mixture was brought down to -5 °C by using 
ice/salt bath. Then an aliquot from the stock solution of diphenylchlorophosphate (100 mL, 0.042 
mmol, 1 equiv) was added slowly to the flask and the reaction mixture was then brought up to 
room temperature. The reaction was then allowed to stir overnight under N2 at room temperature. 
The reaction was monitored by TLC (69% hexane, 30% isopropanol, 1% acetic acid) and then 2 
mL of distilled water and 5 mL of ethyl acetate was added to the reaction mixture. The aqueous 
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layer was separated and washed twice with 5 mL of ethyl acetate. The organic layers were 
combined, and washed with 5mL 1.0 M HCl, 5 mL saturated NaHCO3 and 5 mL H2O in 
sequence, then dried over anhydrous Na2SO4 and concentrated in vacuo to afford the crude 
product (0.088g). The crude was then purified by silica gel flash column chromatography with a 
solvent system of hexane/ethyl acetate (4:1) and the fractions containing the desired product 
were combined, dried over anhydrous Na2SO4 and concentrated in vacuo to afford 0.048 g of the 
product with impurities. 1H NMR (methanol-d4) δ = 8.2 (2H) and 7.71 ppm (AA’XX’, apparent 
doublets), 7.24-7.30 (4H, m), 7.05 (1H, t, J = 7.2 Hz), 5.23 (1H, d, 2 Hz), 4.56 (2H, s), 4.37 (1H, 
d, J = 2 Hz). 
     
















This experimental procedure was adapted from Mitchell and Finney (34). This reaction was 
repeated in a large scale with a racemic mixture of trans-1,2-diaminocyclohexane. In a 100 mL 
round-bottomed flask, ethyl acetimidate hydrochloride (8.75g, 0.071 mol, 1.0 equiv) was 
dissolved in 90 mL of ethanol at room temperature, and the reaction flask was then transferred to 
0 °C bath under an N2 atmosphere. Via syringe, an aliquot of trans-1,2-diaminocyclohexane 
(8.50 mL, 0.071 mol, 1.0 equiv, racemic mixture) was added to the reaction flask and it was then 
brought up to room temperature. The reaction was allowed to proceed overnight, and was then 
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quenched with 150 mL of 1.0 M NaOH. The solution was then extracted three times with 100 
mL of 5% MeOH/CH2Cl2, and the organic layers were combined, dried over Na2SO4 and 
concentrated in vacuo to afford 9.99 g of crude product. The crude product was then dissolved in 
260 mL of ethanol/H2O (1:1 v/v) and refluxed overnight. The reaction solution was then 
concentrated, dried over anhydrous Na2SO4 and concentrated again in vacuo to afford the crude 
product (10.5 g). The crude product was checked against the starting material on TLC (85% 
MeOH, 14% CH2Cl2 and 1% NH4OH v/v/v) and residual starting material was still observed. 
Then 9.29 g of the crude product was purified though silica gel flash column chromatography 
with the same solvent system as used in TLC. The combined fractions containing the desired 
compound were then concentrated in vacuo to afford 7.58 g of the product (racemic mixture) 
with an overall yield of 68.3%.  
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This experimental procedure was adapted from Luo et al. (26). The large scale reaction was 
continued from the racemic mixture of trans-2-aminocyclohexylacetamide. In a 250 mL round-
bottomed flask, the racemic mixture of trans-2-aminocyclohexylacetamide (7.47 g, 0.048 mol, 
1.0 equiv) was dissolved in100 mL of acetonitrile, followed by addition of 13 mL of distilled 
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H2O. Then propionaldehyde (17.2 mL, 0.24 mol, 5.0 equiv) was delivered into the reaction flask 
via syringe and the mixture was allowed to stir for 20 min at room temperature under an N2 
atmosphere. Then a solution of 1.0 M NaCNBH3 in THF (96 mL, 0.096 mol, 2.0 equiv) was 
transferred into the flask via syringe and the mixture was stirred for 20 min at room temperature 
under N2. At this stage, 15 mL of glacial acetic acid was added to the flask and the mixture was 
stirred for 2 hours at room temperature under N2 atmosphere. The solvents were then removed in 
vacuo and the reaction mixture was taken up in 200 mL of ethyl acetate and washed three times 
with 100 mL of 1 M NaOH and 100 mL of brine. The organic layer was dried over anhydrous 
Na2SO4 and concentrated in vacuo. The crude mixture was taken up in 200 mL of 4.0 M aqueous 
HCl and refluxed overnight under an N2 atmosphere. The reaction mixture was cooled to room 
temperature and then the pH of the solution was adjusted to approximately 13 using 250 mL of 
4.0 M NaOH. The aqueous layer was then extracted three times with 200 mL of CH2Cl2 and the 
organic layers were combined, dried over anhydrous Na2SO4 and concentrated in vacuo to afford 
8.14 g of crude product. The crude product was purified by vacuum distillation (boiling point is 
75-77 °C at 0.5 torr) and two fractions were collected. The second fraction was found to contain 
impurities by 1H NMR and only the first fraction was saved and identified to contain 4.61 g of 
the pure product. The proton and carbon NMR spectra agreed very well with the data provided in 


















The racemic mixture of N, N-dipropylcyclohexane-1,2-diamine (4.43 g, 0.022 mol, 1 equiv) was 
diluted with 5.0 mL of dry CH2Cl2 in a 10 mL volumetric flask under an N2 atmosphere. The 
glass ampule containing triflic acid was opened carefully under an N2 bath where the N2 was 
blowing from an inverted glass funnel. Then the triflic acid (1.97 mL, 0.022 mol, 1 equiv) was 
carefully transferred from the ampule to the flask very slowly via syringe. Then dry CH2Cl2 was 
added to the flask to fill up the volume under N2 and the solution was carefully mixed to afford 















Development of novel inhibitors of Class II FBP aldolases 
 
3.1 Introduction 
Class II FBP aldolases have been proposed to be potential drug targets since they are not 
present in higher organisms such as animals and plants (1, 2). Ideally, selective inhibition of 
microbial Class II FBP aldolases would affect a major metabolic pathway of pathogens by 
disrupting glycolysis, thereby hindering their survival and persistence within the host. To date, 
there are only limited numbers of publications associated with the development of Class II FBP 
aldolase inhibitors (1, 3-5), and the inhibitors have largely been found to be either non-selective 
or of low potency. Our research group is interested in developing a selective and more effective 
inhibitor towards Class II FBP aldolases, and has already obtained some preliminary results. This 
chapter of the thesis focuses on the design and synthesis of small compounds which will be 
tested against Class II FBP aldolases. Furthermore, Class II FBP aldolases belong to the zinc 
protease family by possessing a catalytic zinc ion in the enzyme active sites. Numerous zinc 
protease inhibitor designing strategies have been described and they are quite valuable to this 








3.2 Strategies for the design of zinc protease inhibitors  
Zinc proteases such as the angiotensin converting enzymes and the matrix metalloproteases 
(MMP) are part of a major family of enzymes characterized by having a catalytically essential 
zinc ion at their active sites (6, 7). Among all the zinc proteases, carboxypeptidase A (CPA) is 
the most extensively investigated enzyme. CPA has been used as a model for developing 
inhibitor design strategies which can be applied to other enzymes such as MMPs (6-8).  
 
MMPs are important endopeptidases functioning in tissue remodelling, organ development, 
ovulation, embryogenesis and angiogenesis, and in addition, are implicated in numerous 
pathological conditions including cancer growth, tumor angiogenesis, arthritis, cardiovascular 
and autoimmune diseases. Therefore, due to the significant association between the pathological 
conditions with the disregulation of MMP activity, inhibitors targeting this type of enzyme have 
drawn great attention for drug development (7, 9, 10).  
 
Notably, almost all the zinc protease inhibitors are designed with at least 2 pharmacophores, a 
zinc binding group (ZBG) and a peptide-like group. The ZBG will coordinate with the zinc atom 
and the peptide-like group is able to fit into one or more substrate recognition sites (11). 
Generally, ZBGs are metal-binding groups such as hydroxamate, carboxylates, thiols, or 
sulfamides, which are capable of binding to the zinc ion in the enzyme active site. The 
hydroxamate ZBG is thought to be the most common and powerful one due to its strong metal 
binding ability (11, 12). Giavazzi and Taraboletti (13) discussed the extensive application of 
hydroxamate-based inhibitors of MMPs in different clinical trials as potential cancer therapies. 
Although such compounds are effective, most of the candidates failed due to observed adverse 
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effects or major toxicity that emerged at high doses. As a result of the undesirable side effects 
and the high non-specific transition-metal binding ability, the hydroxamate-based inhibitors are 
no longer being used; while other types of inhibitors with ZBGs such as carboxylate, 
phosphonate, and thiol groups are sought instead. Nonetheless, a loss of activity when compared 
to the hydroxamate counterpart due to the structural change was observed (11). Moreover, 
sulfamide-based and sulfamide-derivative inhibitors were synthesized as transition state 
analogues and proved to be effective novel inhibitors of CPA (6, 8). Lee and Kim (7) also found 
that thiol groups form stronger coordination with the active site zinc ion than carboxylate groups 
when they evaluated a mono-thiol substituted compound instead of a dicarboxylate substituted 
compound against CPA.  
 
Importantly, inhibitor design should not only be focused on the specificity of the ZBGs, but 
also on the other core peptide-like structure which is capable of interacting with the specific 
binding pocket of the enzyme active site. Generally, inhibitor discovery can be accomplished 
through natural product screening, substrate-derived analogue-based drug design, mechanism-









3.3 Existing Class II FBP aldolase inhibitors  
The inhibitor design strategies from the previous work on the zinc proteases directed us on the 
design of inhibitor for Class II FBP aldolase, since the enzyme also requires an essential divalent 
metal to participate in catalysis. In the case of E. coli and M. tuberculosis, a zinc ion is found in 
the enzyme active site (15, 16). Surprisingly, while numerous inhibitors of Class I FBP aldolase 
have been synthesized and tested (17), only a few inhibitors of Class II FBP aldolase have been 
reported. The first potent inhibitor was synthesized and reported by Lewis and Lowe (1). 
Phosphoglycolohydroxamic acid (PGH), a remarkable competitive inhibitor of yeast class II FBP 
aldolase with a Ki of 0.01 μM, is less active while still potent towards rabbit muscle Class I FBP 
aldolase with a Ki of 1 μM. The selectivity of PGH for Class II FBP aldolases is determined to be 
100 by comparing the Ki values (18).  The reported crystal structure of E. coli Class II FBP 
aldolase by Hall et al. in the presence of PGH revealed that this compound is not only a powerful 
zinc chelator, but also a stable analogue of the enediolate intermediate (as the T.S.I. in Figure 3-1) 
(19). However, the high potency of PGH towards Class I FBP aldolase prevents its application as 
a drug. Recently, based on the phosphoglycolate skeleton of PGH, Fonvielle et al. (3) 
synthesized two PGH derivatives (Figure 3-2) in which the hydroxamate was replaced either by 
an amidoxime or by a hydrazide moiety instead of the hydroxamate, and found these inhibitors to 
be more selective towards yeast Class II FBP aldolases, although less potent than PGH (Ki of 
PGA is 2.3 μM and Ki of PGHz is 0.34 μM). Based on these results, Gavalda et al. (4) prepared a 
new family of inhibitors possessing the phosphoglycolate skeleton bound to a sulfamate group 
(Figure 3-2). They suggested that compounds with an NH moiety between the carbonyl and 
sulfonyl groups are very acidic; thus the negative charge at this position of PGS would improve 




















         PGH                    PGA                        PGHz              T.S.I.                  DHAP  
Figure 3-1. Structures of PGH and its derivatives. The compounds in the figure are PGA 
(amidoxime), PGHz (hydrazide), T.S.I. (Transition state intermediate formed by protonation of 
















PGH (X = O)                          PGS1 (X = O, R = CH3)
p-PGH (X = CH2)                   PGS2 (X = O, R = Ph)
                                                p-PGS1 (X = CH2, R = CH3)
                                                p-PGS2 (X = CH2, R = Ph)  
 
Figure 3-2. Structures of PGH, phosphoglycolosulfamate (PGS) and their phosphonate 
derivatives (4).  
 
 
In addition, PGS1 and PGS2 were both found to be competitive inhibitors of E. coli Class II 
FBP aldolase (Ki values are 350 and 100 μM, respectively), indicating the active site binding 
affinity is dependent on the chemical group bound to the sulfamate moiety. Nevertheless, the 
structural modification of converting phosphate into phosphonate weakened the inhibitor binding 
significantly (Ki values are greater than 10 mM for p-PGS1 and p-PGS2); the phosphonate 
derivatives were designed due to their exceptional stability towards phosphatases compared to 
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the phosphates under physiological conditions. From these results it was deduced that the ester 
oxygen of the phosphate moiety is critical for the inhibitor binding and stable interaction with the 
enzyme active site (4).  
 
Preliminary results from our research group obtained by the screening of metal binding agents 















DPA                                                 MS191                                                          DMPS
 
Figure 3-3. Structures of DPA and its derivatives MS 191, and commercial antidote for heavy 
metal poisoning 2,3-dimercapto-1-propanesulfonic acid (DMPS).  
 
 
Class II FBP aldolases (IC50 = 40 μM for M. tuberculosis and IC50 = 75 μM for P. aeruginosa), 
whereas no measurable inhibitory activity towards Class I FBP aldolase from rabbit muscle was 
observed (Geneviève Labbé, unpublished results). Although DPA is a well known metal 
chelating agent, kinetic studies of DPA as an inhibitor of yeast Class II FBP aldolase are 
consistent with active site binding without metal ion removal. Molecular modelling led M.D.R. 
Brown in our group to construct a phosphonate DPA derivative (MS191) (Figure 3-3) and it was 
found to be a good inhibitor with an IC50 of 90 μM towards yeast Class II FBP aldolase while not 
inhibiting the Class I counterpart. In order to screen for a better inhibitor, compounds with 
modifications on the pyridine ring were prepared by Timothy Rasmusson and Dr. Muhong Shang 
 66
to introduce appropriate functional groups. Unfortunately, none was found as effective as DPA 
or MS 191. Furthermore, in our recent studies, a commercial antidote for heavy metal poisoning, 
2,3-dimercapto-1-propanesulfonic acid (DMPS) (Figure 3-3) was found to be a good inhibitor 
with an IC50 of 5 μM for M. tuberculosis enzyme and IC50 of 40 μM for M. grisea enzyme. 
Meanwhile, no inhibitory activity was observed toward Class I FBP aldolase from rabbit muscle, 
and the inhibition was shown to be reversible without metal ion removal. Moreover, DMPS had 
been previously found in our group to be a moderately effective inhibitor of metallo-β-

















3.4 Development of novel Class II FBP aldolase inhibitors  
The observation that DMPS is not inhibitory towards the Class I FBP aldolase from rabbit 
muscle indicates that rationally designed structural variants of DMPS may exhibit selectivity and 
specificity towards Class II FBP aldolases. Furthermore, the failure of this compound to inhibit 
Class I FBP aldolase also proved DMPS is not inhibitory towards triose phosphate isomerase 
(TIM), an essential mammalian enzyme as well as an integral part of the coupled-enzyme assay 
which is used to evaluate the inhibitory activity of compounds towards the Class II enzymes as 
discussed in chapter 2. Interestingly, one drawback of the aforementioned powerful inhibitor 
PGH is that it inhibits both Class I FBP aldolases and TIM significantly (18).  
 
A molecular modeling study was recently performed by T. Ramadhar and G. Labbé involving 
the docking of a model of DMPS into the x-ray crystal structure of E. coli Class II FBP aldolase 
(PDB code 1B57) followed by energy minimization. The study revealed that this compound 
should be capable of binding to the active site of Class II FBP aldolases. However, when the 
sulfonate moiety is located in the phosphate binding pocket, only the terminal SH group can 
coordinate with the zinc ion in the active site whereas the secondary SH group is too far from the 
zinc ion to allow strong interaction (Figure 3-4). The number of atoms separating the sulfonate 
group and the zinc binding thiols in DMPS are different by one to the phosphate group and the 
zinc binding hydroxyl oxygen in PGH. We then proposed a new compound, 1,1-difluoro-3,4-
dimercaptobutylphosphonic acid (3-2 in Figure 3-5) which contains an extended carbon skeleton 
with a phosphonate group instead of a sulfonate group based on the structure of DMPS (3-1 in 
Figure 3-5) and the enediolate intermediate. This compound is expected to be a somewhat better 
inhibitor since the spatial relationship between the thiol groups 
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Figure 3-4. Docking of a model of DMPS into the substrate binding site of E. coli Class II FBP 
aldolase. The crystal structure was adapted from PDB 1B57. In the figure, the atoms are zinc 





















Figure 3-5. Structures of 2,3-dimercaptopropane-1-sulfonic acid (DMPS) and the proposed 




and the phosphonate groups might allow for a better interaction of both thiol groups with the 
active site zinc ion than appeared to be the case in modelling studies with DMPS. In the structure 
3-2 in Figure 3-5, the two fluorine atoms are expected to allow for favourable H-bonding 
interactions with the functional groups in the active site which normally H-bond to the phosphate 
oxygen atom attached to C-1 of DHAP.  
 
The proposal of compound 3-2 was then further supported by the molecular modeling studies 
performed by T. Ramadhar and G. Labbé (Figure 3-6). They docked the model of compound 3-2 
into the E. coli Class II FBP aldolase (PDB code 1B57) active site, and a comparison was done 
between this model and the previous DMPS model. The result reveals that the extension of the  
 
 
Figure 3-6. Docking of a model of 1,1-difluoro-3,4-dimercaptobutylphosphonic acid into the 
substrate binding site of E. coli Class II FBP aldolase. The modeling was done with SYBYL 7.3 
(Tripos) using the MMFF94 force field and the Anneal function. The crystal structure of the E. 
coli Class II FBP aldolase is adapted from PDB 1B57. In the figure, the atoms are zinc (magenta), 




carbon skeleton by one methylene group of DMPS allows the secondary thiol group in 
compound 3-2 to bind to the zinc ion with a stronger interaction. The terminal thiol and the 
secondary thiol groups were found to be 3.35 Å and 2.82 Å from the zinc ion, respectively, 
suggesting a strong interaction among them. The pro-R fluorine was found to be 2.78 Å from a 
water molecule which is H-bonding with Thr-289 and Glu-182 and in van der Waals interaction 
with the imidazole ring of His-226. Furthermore, the pro-S fluorine was found to be in van der 
Waals interaction with the amide nitrogen which is between His-264 and Gly-265. Therefore, the 
goal of the present study was the synthesis of compound 3-2 as a potential inhibitor for Class II 




































It was proposed that the dithiolphosphonate 3-2 might be formed from a precursor 3-3 in 
which the thiol and phosphonate groups are appropriately protected. It was further imagined that 
nucleophilic displacement of proper leaving groups (e.g. X = Br) by a suitable sulfur nucleophile 
on a precursor such as 3-4 could lead to formation of 3-3. The alkene 3-5 was thought to be a 
suitable precursor for 3-4 and the formation of 3-5 was considered to be possible using an allyl 
system 3-6 with a suitable leaving group as an electrophile in an SN2 reaction with a 
difluorophosphonate anion. The difluorophosphonate anion could be formed by deprotonation of 
























EtO 3-8  
    The starting material 3-8, which was used as the precursor of the alkylation compound, has 
been previously reported in the literature. This compound can be prepared via a Michaelis-
Arbuzov reaction between triethylphosphite and bromodifluoromethane (Scheme 3-2) (21). 
Alternatively, 3-8 can be obtained via SN2 reaction of chlorodifluoromethane with the anion 










































Interestingly, diethyl phosphite 3-9 exists in equilibrium with its tautomer diethyl phosphonate 
3-10, with 3-10 being more stable by approximately 6 kcal/mol through Density Function 
Transform (DFT) calculation as recently reported by Rai and Namboothiri (22). Both 3-9 and 3-
10 can form the same conjugate base 3-11 which is a resonance hybrid of the contributors 3-11a 
and 3-11b. It is generally described that the phosphorus atom in the anion is the most 
nucleophilic site and reacts with various electrophiles to provide the phosphonate derivative 3-13 






































EtO 3-8  
Scheme 3-5 
 
    In this research group, Dr. Christopher Lanthier has previously prepared a sample of 
compound 3-8 using the method involving alkylation of the anion 3-11 by 
chlorodifluoromethane (Scheme 3-5), followed by purification by distillation. This sample was 
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hence made available as the starting material for the present study. Since the description of the 
spectroscopic characteristics of 3-8 in the literature is not very detailed, the 1H NMR of 3-8 was 
analyzed and interesting features were revealed.  
 
Due to the fact that both 19F and 31P nuclei are NMR active with spin ½, the C-H signal in 3-8 
consists of a triplet of doublets with a J (1H-19F) = 48 Hz and a J (1H-31P) = 27 Hz. In addition, 
the hydrogens within each ethoxy CH2 group are diastereotopic so that each ethyl (-CH2CH3)  
group is actually an AA'X3 system in the Pople nomenclature. Therefore the hydrogens within 
each -CH2 group are expected to couple with one another. Because the chemical shift difference 
between HA and HA' is very small, the spin system is non-first order and the splitting pattern is 
not predictable by simple first order analyses, which applies only when Δν/J ratio is large. 
Additionally, there appears to be a contaminant that contains an [31P-X-CH-19F] system as 
indicated in the 1H NMR by the small signals beside each of the lines in the triplet of doublets of 
the major product. The nature of the impurity is not clear, however, it may represent compound 
3-14, the product of “O” alkylation of the anion 3-11. In any event, the phosphonate compound 
3-8, along with its contaminant, was used as the starting material in the present study. The 
deprotonation of 3-8 followed by reaction with various electrophiles including allyl bromide was 
reported previously in a communication by Obayashi et al. (23). Unfortunately, very little 
information was provided by the authors in regard of the experimental conditions and no 









In the present study, the anion form of 3-8 was generated using lithium diisopropylamide 
(LDA) prepared by reaction of dry diisopropylamine with n-butyllithium in anhydrous THF. 
Once the anion had been prepared, allyl bromide was added and the reaction mixture was 
allowed to stir at 0 °C. It was proved to be difficult to monitor the progress of the reaction by 
TLC in the usual way; hence an arbitrary reaction time of 2 hours was used. The reaction was 
quenched by saturated NH4Cl solution and worked up with ethyl acetate to afford the crude 
product, which contained signals arising from the starting material 3-8 as well as from the 
desired allylation product 3-15. The terminal vinyl hydrogens at C-4 in compound 3-15 give rise 




















= 5.25 to δ = 5.31 ppm in the 1H NMR spectrum. The single vinyl hydrogen attached to C-3 
appears as a multiplet overlapping with the triplet of doublets from the C-H of the starting 
material 3-8. The crude allylation product also contained a minor impurity (approximately 10%) 
that exhibited multiplets in the vinyl hydrogen region. This impurity may have arisen from the 
impurity present in the starting material 3-8, but there is insufficient evidence to establish the 
structure of this compound. The two hydrogens at C-2 give rise to a complex but symmetrical 
multiplet from δ = 2.74 to δ = 2.94 ppm. This is consistent with two hydrogens coupled to two 
19F nuclei and one 31P nucleus on an adjacent carbon atom in addition to the coupling to a vicinal 
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hydrogen (-C(H)=C-), and possibly the weak allylic coupling to the terminal hydrogens (-
C=CH2).  
Attempts to find a solvent system that might allow separation of the allylated product 3-15 
from the starting material 3-8 by silica gel flash chromatography were unsuccessful. Thus the 
crude reaction product was reacted further with molecular bromine in order to synthesize the 
next product.  
 
The reaction was continued by mixing the crude allylation product with a solution of 
molecular bromine (1 equivalent) in dichloromethane followed by purification with silica gel 
flash chromatography, giving a combined fraction that containing the desired product 3-16 as 
well as a minor impurity. The presence of the desired dibromide product was suggested by the 





















spectrum. The presence of the two ethoxy groups was indicated by a multiplet (apparent 
“quintet”). The diastereotopic hydrogens of the two CH2 groups were found at δ = 4.20 and δ = 
4.35 ppm and a triplet of six protons was found at δ = 1.39 ppm (J = 7.1 Hz). Two very complex 
but symmetrical multiplets at δ = 2.96 to δ = 3.19 and δ = 2.55 to δ = 2.79 ppm can be assigned 
to the two hydrogens attached to C-2 near the -CF2 group and the phosphorus atom. Two 
doublets of doublets at δ = 3.72 (J = 7.6, J = 10.9 Hz) and δ = 3.90 ppm (J = 4.5, J = 10.9 Hz) 
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are assigned to the two diastereotopic hydrogens at C-4, which coupled to one another and to the 
hydrogen at C-3. The C-3 hydrogen gives rise to a symmetrical multiplet at δ = 4.53 ppm, which 
includes coupling to the non-equivalent hydrogens at C-2 and C-4, and perhaps some long range 
coupling to 19F and 31P.  
 
The 13C NMR spectrum of this fraction was also helpful in confirming the presence of the 
dibromide compound 3-16. In the J-MOD spectrum, where CH3 and CH carbons are phased 
downwards while CH2 and quaternary carbons are phased upwards, the singlet at δ = 16 ppm 
(downwards) is assigned to the –CH3 of the ethoxy groups. The singlet (upwards) at δ = 64.5 
ppm is assigned to the -CH2 of the ethoxy groups. The signal (downwards) at δ = 42 ppm is 
assigned to the (C-3)-HBr group, and upon scale expansion at high digital resolution, it was 
found to be a six line symmetrical multiplet as a result of long range coupling to the two 19F 
nuclei and the 31P nucleus. Then the (C-4)-H2Br group is assigned to the singlet (upwards) at δ = 
37.2 ppm. The more complex multiplets at δ = 40.6 ppm and δ = 119.2 ppm clearly must 
represent carbons that are coupled to 19F or 31P or both since the spectrum is decoupled from 1H 
nuclei. The most downfield signal is a doublet of triplets with a JC-F = 261 Hz and JC-F = 215 Hz 
and is assigned to the 31P-C19F2 (C-1) group. The multiplet at δ = 40.6 ppm (J =15.5 Hz, J = 20.1 
Hz) is also in a six line pattern (doublet of triplets) with smaller 13C to 19F and 31P coupling 
constants; thus, it is assigned to C-2 atom.  
 
The presence of the dibromide compound 3-16 is further confirmed by the mass spectrum of 
the purified bromination product obtained by chemical ionization (CI) with ammonia as the bath 
gas shows a three peak pattern at m/z = 404, 406, and 408 in a 1:2:1 ratio, respectively. This is a 
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result of the presence of (M+NH4+) ions of 79Br79Br, 81Br79Br (79Br81Br) and 81Br81Br isotopomer 
combinations of the dibromide product 3-16. A weaker set of three signals at m/z = 387, 389, 
391 corresponding to the (M+H+) ions for the isotopomeric dibromides was also observed.  
 
Interestingly, an additional set of three signals at m/z = 384, 386 and 388 is consistent with the 
presence of ions derived from a molecule that retains the two bromine atoms but has somehow 
lost a HF fragment [i.e. (M–HF+NH4+)]. This observation proved to be of some significance in 




































    Initially, it was proposed that the impurity that gives rise to the sets of complex symmetrical 
mutiplets in the 1H NMR spectrum of the dibromide product might be the tribromide compound 
3-17 as shown above (Scheme 3-6). This tribromide compound might arise by some competing 
free radical chain bromination preceding the ionic addition of Br2 to the C=C bond. However, 
signals in the mass spectrum corresponding to the tribromide compound were not found. 
Furthermore, the chemical shifts from the impurity of the 1H NMR agree poorly with those  
for the tribromide product, thus leading us to consider other possible structures corresponding to 
the impurity instead. The presence of a multiplet at δ = 6.11 ppm in the 1H NMR with large 
coupling constant is suggestive of a vinyl proton in proximity to the fluorine atoms and the 
phosphorus atom. This suggested the possibility of a structure derived by loss of a HF fragment 
as detected in the mass spectrum described above should be considered. In particular, it was 
proposed that the major impurity in the dibromide sample (approximately 13%) is the 
unsaturated dibromide 3-18 shown below with the chemical shifts and coupling constants 
indicated for specific hydrogens (Scheme 3-7).  
 
    As indicated in Scheme 3-7, the chemical shifts predicated by application of the incremental 
additivity rules for substituents as implemented in ChemDraw Ultra 8 for the hydrogens in the 
tribromide structure agree poorly with those obtained experimentally for the impurity from the 
dibromide product. In particular, the hydrogen at C-2 which is expected to be coupled to the two 
fluorine atoms and the phosphorus atom in the tribromide structure 3-17 is predicted to have a 
chemical shift of 4.4 ppm, whereas this hydrogen was found at 6.11 ppm experimentally. For the 
vinylfluoride-dibromide structure 3-18 of the impurity, the predicted chemical shift for the vinyl 
hydrogen is in better agreement (δ = 5.85 ppm). Moreover, the observed coupling constant JH-F 
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(34.4 Hz) is in the range expected for a trans relationship between a fluorine and hydrogen atom 
on a C=C bond.   
 














δ = 6.11 ppm ddd ( J = 34.4, 10.7 and 7.1 Hz)
δ = 3.80  ppm dd ( J = 10.1 and 4.4 Hz)
δ = 3.61  ppm dd ( J = 10.3 and 10.8 Hz)















































Further evidence to support the presence of 3-18 is from the 13C NMR spectrum of the 
dibromide/impurity mixture. It shows a downfield signal at δ = 153.0 ppm that is a double of 
doublets with J = 286 and 228 Hz that is consistent with a carbon with one fluorine and one 
phosphorus atom attached. The J-MOD spectrum also includes a doublet of doublets at δ = 123.4 
ppm with J =29 and 4 Hz which is phased downwards. This signal matches with a vinyl carbon 
with one hydrogen attached and one fluorine plus one phosphorus atoms at the adjacent vinyl 
carbon atom.  
 
Noticeably, examination of the literature shows that there have been some recent efforts to 
synthesize α-fluorinated phosphonates. For example, Prestwich and coworkers have reported that 
Wadsworth-Emmons reaction of α-fluorovinylphosphonates with various aldehydes provides 






































Interestingly, as shown in the 1H and 13C NMR characteristics (Scheme 3-9) of the authentic α-
fluorinated phosphonates prepared by the authors agree well with those of the impurity in the 
bromination reaction. It is however not clear how this vinylfluoride arises in the bromination 
reaction. One possibility is that it might arise from the impurity present in the starting allyl 




































δ 5.99  ddd, J =39.2, 7.6, 7.6 Hzδ 6.11  ddd, J =34.4, 10.7, 7.1 Hz
δ 123.4  dd, J =29, 2.8 Hz δ 124.4  dd, J =28, 3.0 Hz




The dibromide product 3-16 was not purified further but was used with the impurity present to 
be carried along in attempts of a double SN2 displacement of the two bromides by conjugate base 
of thioacetic acid. This conjugate base was generated by reaction of thioacetic acid with 
diazabicyclo-undec-7-ene (DBU) in dimethyl formamide (DMF) as the solvent. Then 3-16 was 
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added slowly as a solution in DMF to the conjugate base solution and the reaction was allowed 
to proceed at room temperature overnight. After an aqueous work-up, TLC analysis of the crude 
product indicated that the starting material had been all consumed and three spots suggesting 























































Initial analysis of the 1H NMR spectrum revealed the presence of vinyl proton signals as 
multiplets at δ = 6.21 and 5.85 ppm. This was suggestive of the major product to be the result of 
elimination (3-19 or 3-20, Scheme 3-10) rather than the desired double nucleophilic 
displacement reaction. In addition, signals found in the range of δ = 3.1 to 3.4 ppm were 
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compatible with the formation of some substitution product. Also, three singlets found in the 
range of 2.2 to 2.4 ppm might be indicative of incorporation of thioacetyl groups into some of 
the products.  
 
Fortunately, results from mass spectrometry by examining the sample with chemical 
ionization and ammonia as the bath gas provided some insight into the possible composition of 
the crude product. The most intense peak was found at m/z = 320, corresponding to an [M+18]+ 
fragment for the product of SN2 displacement of one bromide by a thioacetyl nucleophile as well 
as E2 elimination of HBr. The second most intense peak found in the CI-MS is at m/z = 396, 
which could be attributed to the ideal situation that both bromides had been displaced by 
thioacetyl anion nucleophiles as desired. Furthermore, two peaks of equal intensity were 
observed at m/z = 400 and 402, which could correspond to the [M+18]+ fragment for the two 
isotopomers of a product that only one bromide had been displaced through an SN2 reaction.  
 
The possible structure of the elimination product was then deduced to be 3-20 rather than 3-19 
based on the multiplicities of the two vinyl hydrogen signals. It was observed that, one of the 
vinyl hydrogen signal at δ = 5.85 ppm exhibiting a quartet with a large coupling constant and 
some additional small coupling (Figure 3-7). The pattern might arise if it was the result of the 
vinyl hydrogen coupling to the two fluorine atoms as well as to the vicinal trans hydrogen with 
the H-F and H-H coupling constants being very similar (approximately 15 Hz). In addition, 
neither of the vinyl hydrogens in 3-19 was expected to possess such a large coupling to fluorine, 
however, it seemed reasonable to suggest that the vinyl hydrogen on C-2 in structure 3-20 might 
couple to the two fluorine atoms with a 3JH-F of approximately 15 Hz. Standard tabulations of 
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coupling constants of protons to heteroatoms suggest that, if the intervening carbon atom is sp3 
hybridized then the 3JH-F values are found in the fairly broad range of 3 to 24 Hz (25). However, 
the value of 3JH-P was found in the range of 15-20 Hz, thus not as small as suggested in the 





Figure 3-7. The apparent quartet and the splitting pattern of the C-2 hydrogen on 3-20 as seen on 
the 1H NMR spectrum. 
 
    A search of the literature was then performed in order to find structures that were similar to 
3-20 with 3JH-F and 3JH-P values reported. One such example was found in the work of Percy and 
coworkers (26) who prepared ethyl (2E)-4-(diethoxyphosphoryl)-4,4-difluorobut-2-enoate 3-24  
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by reaction of triethyl phosphonoacetate with the difluorophosphonate derivative 3-23 (Scheme 
3-11).  The trans H-H coupling for the hydrogen at C-2 was found to be 15.5 Hz, whereas the 
3JH-F value was found to be 12.5 Hz. Also, the 3JH-P value was found to be merely 2.5 Hz. 
Therefore, 3JH-P values for hydrogen bound to an sp2 hybridized carbon appear to be much 
smaller than those observed when the hydrogen is attached to an sp3 centre. Thus, the 
interpretation of the NMR data in favour of the structure 3-20 rather than 3-19 seems valid. In 
addition, the other vinyl hydrogen on C-3 in 3-20 gives rise to a complex, but symmetrical, 
multiplet that includes coupling to the hydrogen on C-2, weaker long range coupling to the two 
fluorine atoms, to the phosphorus atom and to the hydrogens on C-4 (-CH2-). The CH2 group 

























The presence of four doublets of doublets in the range of 3.16 to 3.55 ppm observed on the 1H 
NMR spectrum might be assigned to the two diastereotopic hydrogens on C-4 of products 3-21 
and 3-22. This is consistent with the mass spectrometric data which implicated the presence of 
these two compounds. These signals are of comparable intensity, suggesting that comparable 
amount of the monosubstitution (3-22) and disubstitution (3-21) products are present. The 
methylene hydrogens at C-2 which are coupled to the two fluorine atoms and phosphorus atom 
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were assigned to the multiplets in the range of 2.3 to 2.8 ppm. The remaining hydrogens from 3-
21 and 3-22 were presumably hidden under the multiplets from the ethoxy group in the range of 
4.0 to 4.3 ppm on the 1H NMR spectrum.  
 
Since E2 elimination reactions tend to be favoured at high temperatures relative to SN2 
reactions, the reaction was repeated at lower temperature (i.e. -20 °C). It was possible to 
decrease the proportion of elimination product present as indicated by analysis of the proton 
NMR spectrum of the crude reaction product. However, both the monosubstitution and 
disubstitution products were found to be present. Due to the limits in time and the amounts of the 
dibromide 3-16 that were available, the study of this approach to the synthesis of the dithiol 














3.6 Future work  
On top of the difficulty of the synthetic route of 3-2 with the method described, one potential 
drawback of this DMPS derivative inhibitor is that, the two thiol groups may undergo oxidation 
in vivo and form intermolecular disulfide bonds. This will render the inhibitor losing the 
capability to bind to the zinc ion before reaching the enzyme active site. It will be valuable that 
such a problematic circumstance can be minimized. 
 
Interestingly, recent studies by Mobashery and coworkers have shown that gelatinase A, a 
zinc-dependent MMP can be irreversibly inhibited by rationally designed thioepoxide containing 
inhibitors (27-29). By mimicking the structure of the substrate of gelatinase A, the thioepoxide 
containing inhibitors bind to the zinc ion once in the active site through the thioepoxide moiety. 
The zinc acts as a Lewis acid in catalyzing the ring opening of the thioepoxide and this will lead 
to a nucleophilic attack by a carboxylate group of the glutamate which participates as a general 
base in the normal catalytic mechanism. The formation of the covalent bond between the 
inhibitor and the enzyme is irreversible and will render the enzyme inactivate as is typical of 
mechanism-based inhibitors. It is hoped that the related mechanism may apply to the active site 
of the Class II FBP aldolase such that a covalent bond formation would be achieved with the 
base involved in deprotonating DHAP between the potential inhibitors. It is reasoned that the 








with the starting material 3-8, followed by alkylation and epoxidation. After the conversion from 
epoxide to thioepoxide, 3-25 can be obtained though route A by hydrolysis. It is also analyzed 
that compound 3-2 can be obtained though route B by ring opening of the thiopoxide with 
thioacetic acid and a good base followed by hydrolysis, thus bypassing the original strategy to 






























































3.7 Experimental  
 
General Experimental  
All the reagents used were purchased from Sigma-Aldrich or from Lancaster Synthesis unless 
otherwise stated. All reactions were performed either under argon or nitrogen atmosphere and   
monitored by thin layer chromatography (TLC) using aluminum-backed sheets precoated with 
silica gel (0.2 mm) (EMD Chemical Inc.). TLC plates were analyzed by an ultraviolet lamp (254 
nm). Anhydrous solvents were obtained from the Manual Solvent Purification System (M. Braun 
Inc.). Flash column chromatography was performed using silica gel (230-400 mesh).  
 
The low resolution electron impact (EI), chemical ionization (CI) and electrospray (ESI) mass 
spectra were obtained by Dr. Richard Smith at University of Waterloo. 1H NMR and 13C NMR 
(J-MOD) spectra were obtained on a Bruker Avance-300 (300 MHz) or Avance-500 (500 MHz) 
NMR spectrometer with d-chloroform, d4-methanol and d6-dimethyl sulfoxide as the solvent 
attributed to specific compound. All the molecular modeling studies were performed using a 
computational modeling kit SYBYL 7.3 (Tripos) with the MMFF94 force field by Timothy 
Ramadhar and Geneviève Labbé in the Dr. Dmitrienko group.  
 
Diethyl Difluoromethylphosphonate (3-8) 
    This compound was prepared by Dr. Christopher Lanthier in this group. 1H NMR (300 MHz, 
CDCl3) δ = 5.94 ppm (1H, td, PCF2H, JH-F = 48 Hz, JP-H = 27 Hz), 4.29 ppm (4H, symmetrical 8 
line pattern, O-CH2-CH3), 1.23 (6H, t, J = 7.0 Hz) (31).  
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3-8                                                                                      3-15  
    The experimental procedure was adapted and modified from Durgam et al. (30) To a 100 mL, 
2-neck round-bottomed flask, dry diisopropylamine (3.35 mmol, 0.47 mL, 1.1 equiv) was 
transferred by syringe into anhydrous THF (20 mL) which was being stirred at –78 °C 
(acetone/dry ice bath) under an argon atmosphere. Then a solution of 1.6 M n-butyllithium in 
hexane (3.29 mmol, 2.06 mL, 1.08 equiv) was delivered into the solution slowly, and the 
reaction flask was immediately transferred to a 0 °C bath to allow the reaction to go for 30 min 
under argon. The reaction flask was then transferred back to –78 °C bath and diethyl 
difluoromethylphosphonate (3.05 mmol in 2 mL dry THF, 1 equiv, prepared by Dr. Christopher 
Lanthier in this group) was added slowly to the reaction mixture. The reaction mixture was 
stirred for 30 min under argon and allyl bromide (3.66 mmol, 0.32 mL, 1.2 equiv) was added to 
the reaction mixture slowly. The reaction was then allowed to stir for 2 hours at 0 °C, brought up 
to room temperature and quenched by 150 mL saturated NH4Cl solution. The residual THF was 
removed in vacuo and the mixture was then extracted three times with 40 mL ethyl acetate. The 
organic layer was dried over anhydrous Na2SO4, filtered and concentrated in vacuo to afford the 
crude product (0.40 g). 1H NMR (300 MHz, CDCl3) δ = 5.76-5.86 ppm (1H, m, overlapped with 
signal from CH of 3-8, CF2CH2CH=CH2), 5.25-5.31 (2H, m, C=CH2), 4.21-4.34 (4H, m, 
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OCH2CH3), 2.74-2.94 (2H, symmetrical m, PCF2CH2CH=CH2), 1.38 (6H, t, OCH2CH3 




























Bromine solution (0.80 M) was prepared by adding 0.30 mL of Br2 to a 10 mL volumetric 
flask and then adding dry CH2Cl2 to make up the rest of the volume. The crude mixture 
containing diethyl-1,1-difluorobut-3-enylphosphonate (0.40 g) was dissolved with 4 mL of dry 
CH2Cl2  in a 25 mL round-bottomed flask and stirred at room temperature under argon for 5 
minutes. Then 1.5 mL of the Br2 solution (1.2 mmol) was transferred into the reaction flask 
slowly via syringe. The reaction was allowed to proceed for 1 hr at room temperature and 
monitored by TLC (EtOAc:Hex = 3:7), then quenched by 50 mL of saturated sodium 
thiosulphate. The reaction mixture was then extracted three times with CH2Cl2. The organic 
layers were then combined and dried over anhydrous Na2SO4, and concentrated in vacuo to 
afford 0.41 g of crude product. The crude product was then purified through silica gel flash 
column chromatography (EtOAc:Hex = 1:4). The combined fractions with the desired compound 
were concentrated in vacuo to afford 0.20 g of a clear and colorless oily product that was mostly 
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diethyl-3,4-dibromo-1,1-difluorobutylphosphonate. 1H NMR (300 MHz, CDCl3) δ = 4.53 ppm 
(1H, symmetrical m, CHBr), 4.35 (4H, symmetrical m, OCH2CH3), 3.90 (1H, dd, J = 10.9, 7.6 
Hz), 3.72 (1H, dd, J = 10.9, 4.5 Hz), 2.96-3.19 (1H, m, PCF2CHHCHBrC), 2.55-2.79 (1H, m, 
PCF2CHHCHBrC), 1.39 (6H, t, J = 7.1 Hz). Proton NMR signals were also observed for an 
impurity identified as 3-18 (see page 86 for a discussion). 13C NMR J-MOD (CDCl3) δ = 119.2 
(up, dt), 64.5 (up), 42 (down, dt), 40.6 (up, dt), 37.2 (up), 17.1 (down). Signals were also 
observed for the impurity 3-18, see page 87 for discussion. CI (NH3)–MS: m/z = 404, 406, 408 
(1:2:1 intensity ratio) (M+NH3+) for bromine isotopomers of C8H15Br2F2O3P. Peaks at m/z δ = 
384, 386, 388 (1:2:1 intensity ratio) (M+NH3+) for bromine isotopomers of C8H14Br2FO3P. 
 






































A stock solution of diazabicyclo-undec-7-ene (DBU) (0.25 M) was prepared in a 10 mL 
volumetric flask by dissolving 0.35 mL of 2.48 mmol DBU in DMF. A stock solution of 
thioacetic acid (0.20 M) was prepared in a 10 mL volumetric flask by dissolving 0.17 mL of 1.98 
mmol thioacetic acid in DMF. An aliquot from the DBU stock solution (0.97 mL, 0.24 mmol, 
3.05 equiv) and an aliquot from the thioacetic acid (1.22 mL, 0.24 mmol, 3.1 equiv) were both 
transferred into a 25 mL round-bottomed flask under N2 and stirred at room temperature for 10 
minutes. Diethyl-3,4-dibromo-1,1-difluorobutylphosphonate (30.6 mg, 0.079 mmol, 1 equiv) 
was then dissolved in 2.0 mL of DMF and transferred slowly into the reaction flask containing 
DBU and thioacetic acid. The reaction was allowed to proceed for overnight under N2 at room 
temperature. To monitor the reaction by TLC, a mini work-up was applied due to DMF’s high 
boiling point. In a small vial, 4 mL of distilled water and approximately 1.0 mL of ethyl acetate 
were added. Then 0.1 mL of the sample from the reaction was added to the vial and stirred 
vigorously to form an emulsion. The ethyl acetate layer was then sampled and analyzed by TLC 
(EtOAc:Hex = 3:7). Three spots rather than the spot of the starting material were observed, 
indicating a mixture of three compounds were present. The reaction was then allowed to 
continue overnight at room temperature. The reaction mixture was then diluted with 70 mL of 
brine and then exacted three times with 30 mL of ethyl acetate. The organic layers were 
combined, dried over anhydrous Na2SO4, and concentrated in vacuo to afford 12.9 mg of crude 
product including 3-20, 3-21 and 3-22. Since E2 elimination reactions tend to be favoured at 
high temperatures relative to SN2 reactions, the reaction was repeated at lower temperature. The 
NMR analysis of the mixture is described above on pages 90-94. CI (NH3)-MS: m/z = 320 
(M+NH3+) for C10H17F2O4PS; 396 (M+NH3+) for C12H21F2O5PS2; 400 and 402 (equal intensity) 
(M+NH3+) for bromine isotopomers of C10H18BrF2O4PS. 
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The second trial of this reaction was performed under different experimental conditions. In a 
25 mL round-bottomed flask, diethyl-3,4-dibromo-1,1-difluorobutylphosphonate (13.2 mg, 0.034 
mmol, 1 equiv) was dissolved with 3.0 mL of DMF and then stirred at -20 °C acetone bath 
(temperature was maintained by cooling machine) under N2. An aliquot from the DBU stock 
(0.41 mL, 0.10 mmol, 3 equiv) and an aliquot from the thioacetic acid stock (0.55 mL, 0.11 
mmol, 3.2 equiv) were then transferred to another 25 mL round-bottomed flask and stirred for 20 
min in an ice bath under N2. The DBU and thioacetic acid mixture was then delivered into the 
first reaction flask slowly via syringe and the reaction was allowed to stir overnight at -20 °C 
under N2. To monitor the reaction by TLC, a mini work-up was applied as in the first trial except 
that brine was used instead of distilled water. Observation by TLC indicated the presence of 
residual starting material. The reaction was allowed to continue overnight at -20 °C under N2 
and was then brought up to room temperature. The mixture was then diluted with 70 mL of brine, 
and extracted three times with 20 mL of ethyl acetate. The organic layers were combined, dried 
over anhydrous Na2SO4 and concentrated in vacuo to afford 12.9 mg of crude product including 
both 3-21 and 3-22. 
 
The third trial was performed under the same conditions as the first trial with a larger scale but 
shorter reaction time. In a 25 mL round-bottomed flask, diethyl-3,4-dibromo-1,1-
difluorobutylphosphonate (69.1 mg, 0.18 mmol, 1 equiv) was dissolved in 2.0 mL of DMF. In 
another 25 mL round-bottomed flask, an aliquot from the DBU stock (2.15 mL, 0.53 mmol, 3 
equiv) and an aliquot from the thioacetic acid stock (2.80 mL, 0.55 mmol, 3.1 equiv) were mixed 
and stirred for 10 min at room temperature under N2. The mixture of DBU and thioacetic acid 
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was then transferred to the first reaction flask via syringe slowly and allowed to stir overnight at 
room temperature. To monitor the reaction by TLC, a mini work-up was applied in the same 
fashion as the second trial. The reaction mixture was then diluted with 80 mL of brine and 
extracted three times with 10 mL of ethyl acetate. The organic layers were combined, dried over 
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